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Accompanying this letter is an exposure draft, approved by the Auditing Standards Board (ASB), 
of a proposed Statement on Standards for Attestation Engagements titled Management's 
Discussion and Analysis. This proposed Statement provides guidance to practitioners who may 
be engaged to examine or review management's discussion and analysis prepared pursuant to the 
published rules and regulations of the Securities and Exchange Commission. A summary of why 
the proposed Statement is being issued, what it does, and how it affects and amends existing 
standards also accompanies this letter. 
Comments or suggestions on any aspect of this exposure draft will be welcomed. To facilitate 
consideration of responses by the ASB, to the extent possible, the comments should refer to 
specific paragraphs and include supporting reasons for each suggestion or comment. 
In developing guidance, the ASB considers the relationship between the cost imposed and the 
benefits reasonably expected to be derived from financial statement audits. It also considers the 
differences the auditor may encounter in the audit of the financial statements of smaller entities 
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SUMMARY 
Why Issued 
The Auditing Standards Board (ASB) is considering the issuance of a Statement on Standards for 
Attestation Engagements (SSAE) to provide guidance to practitioners who may be engaged to 
examine or review management's discussion and analysis (MD&A) prepared pursuant to the 
published rules and regulations of the Securities and Exchange Commission (SEC). The ASB has 
observed the following since a proposed SSAE was first issued for exposure in 1987, and 
subsequently deferred: 
• Possible changes may occur in the existing financial reporting model as a result of the 
Comprehensive Model for Business Reporting proposed by the AICPA Special Committee on 
Financial Reporting. Such model is more forward-looking than the current financial reporting 
model; management's discussion and analysis that public registrants are currently required to 
prepare addresses certain elements proposed by the model. 
• During the research performed by the AICPA Special Committee on Financial Reporting, some 
users expressed a desire for more auditor involvement in financial information that they receive. 
• Existing guidance does not address a number of issues practitioners should consider in applying 
the Attestation Standards to an engagement to examine or review MD&A (including whether 
the practitioner needs to have audited or reviewed the financial statements to which the MD&A 
relates; internal control considerations; application of materiality considerations in the 
performance of an examination and in forming an opinion on, or providing the basis for 
reporting on a review of, the MD&A presentation; and the nature of specific procedures that 
should be performed), whether a review level of service is appropriate for MD&A, or whether 
it is appropriate to accept an engagement with respect to a presentation similar to MD&A in 
a non-SEC environment. 
Accordingly, the ASB believes that the profession should be proactive rather than reactive to 
changes in the business environment and be appropriately positioned to provide such service if 
requested. The ASB also believes that the proposed Standard would provide a framework that 
may be useful in providing assurance services in the future as companies experiment with new 
forms of financial presentations, such as the Comprehensive Model for Business Reporting. 
What It Does 
An examination or a review of MD&A would provide a higher level of assurance as to 
reasonableness to both the users and the preparers of the MD&A than is provided today in the 
context of an audit of financial statements. Existing standards included in Statement on Auditing 
Standards (SAS) No. 8, Other Information in Documents Containing Audited Financial Statements 
(AICPA, Professional Standards, vol. 1, AU sec. 550), only require the auditor to read the MD&A 
and consider whether the MD&A, or the manner of its presentation, is materially inconsistent with 
information, or the manner of its presentation, appearing in the financial statements. A comparison 
of the procedures under SAS No. 8 versus an examination or review of MD&A appears in the Table 
at the end of this Summary. 
An examination of MD&A would provide both the users and the preparers with an independent 
opinion regarding whether the presentation includes the required elements of Item 303 of 
Regulation S-K and the related published SEC rules and regulations, whether the historical financial 
information included in the MD&A is accurately derived from the entity's financial statements, and 
whether the underlying information and assumptions of the entity provide a reasonable basis for 
the disclosures contained therein. A review of MD&A would provide users and preparers with 
negative assurance concerning such matters. 
In addition to the assurance that is obtained from an examination or a review level of service, 
management would also benefit by improving the MD&A through an independent view of the 
content. Improvements to the MD&A presentation improve the quality of information available to 
users. Audit committees might benefit through the additional discussions with the auditors and 
review of the draft MD&A presentation that would result from an examination or review 
engagement. 
This proposed Statement provides guidance to assist the practitioner in the following: 
• Accepting an engagement 
• Planning the engagement 
• Considering internal control applicable to the preparation of MD&A 
• Obtaining sufficient evidence for an examination 
• Applying analytical procedures and inquiries for a review 
• Considering events subsequent to the balance-sheet date 
• Reporting 
Fundamental to accepting an engagement to examine MD&A under this proposed Statement is the 
requirement for the practitioner to have audited the financial statements for at least the latest 
period subject to his or her examination of MD&A. Similarly, in order to accept an engagement 
to review MD&A, the practitioner is required to have performed either an audit of the annual 
financial statements or a review of interim financial statements for at least the latest period to 
which the MD&A presentation relates. 
If there is a predecessor practitioner who examined or reviewed the MD&A for a prior period(s), 
the successor practitioner may refer to the reports of the predecessor practitioner for the earlier 
period(s) if the predecessor practitioner's permission is obtained. Otherwise, the successor 
practitioner is required to apply the appropriate procedures relating to information concerning prior 
years included in the current MD&A presentation in order to examine or review such presentation. 
If the practitioner is requested by entities to provide this service, the proposed Statement would 
be applied to engagements by public companies that are required to follow Item 303 of Regulation 
S-K and nonpublic entities that choose to prepare MD&A using the published SEC rules and 
regulations. 
How It Affects Existing Standards 
Although an engagement to perform an examination or review of an MD&A presentation may be 
performed under SSAE No. 1, Attestation Standards, this proposed Statement expands on the 
guidance in such standard by providing specific guidance with respect to engagement acceptance, 
performance issues, and reporting matters for an MD&A presentation. 
SAS No. 8, which requires the auditor to read the MD&A and consider whether the MD&A or its 
presentation is materially inconsistent with information, or the manner of its presentation, 
appearing in the financial statements, would continue to apply to situations in which the auditor 
is not engaged to examine or review the MD&A presentation. 
This proposed SSAE would require amending various paragraphs of SAS No. 72, Letters for 
Underwriters and Certain Other Requesting Parties (AICPA, Professional Standards, vol. 1, AU sec. 
634), to permit accountants to examine or review and report separately on an Item 303 MD&A 
presentation. Accordingly, the proposed amendments to SAS No. 72 are included as an appendix 
to this proposed SSAE. 
Independence 
Commentators to this proposed Statement should be aware that practitioners performing an 
engagement to examine or review MD&A under this proposed Statement must be independent 
pursuant to rule 101 of the Code of Professional Conduct (AICPA, Professional Standards, vol. 2, 
ET sec. 101) because of the required condition that the practitioner has to have audited or 
reviewed historical financial statements for at least the latest period to which the MD&A 
presentation applies. 
Background Information Presentation 
In 1991, the AICPA formed the Special Committee on Financial Reporting to address the following 
questions because of concerns about the relevance and usefulness of business reporting: 
• What information should companies provide to investors and creditors? 
• To what extent should auditors be associated with that information? 
Based upon the Committee's research into the information needs of users and other user concerns 
about the relevance of business reporting in making investment and credit decisions, the 
Committee developed recommendations to improve business reporting. 
The Committee proposed a Comprehensive Model for Business Reporting designed to help focus 
attention on a broader, integrated range of information and to provide the foundation for future 
improvements to business reporting. Such model is more forward-looking than the current financial 
reporting model; management's discussion and analysis that public registrants are currently 
required to prepare addresses certain elements proposed by the model. 
As a result of the recommendations of the Committee, the ASB revitalized the MD&A project 
undertaken in 1987 to provide further guidance for auditor association with MD&A. This proposal 
to provide such guidance not only positions the profession to provide such services if requested 
by public registrants, but it also provides a framework that may be useful in providing assurance 
services in the future as companies experiment with new forms of financial presentations, such 
as the Comprehensive Model for Business Reporting, or as entities other than public companies 
develop a structure (including reasonable criteria) for the preparation of a presentation similar to 
the MD&A required by Item 303 of Regulation S-K. 
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PROPOSED STATEMENT ON STANDARDS FOR ATTESTATION ENGAGEMENTS 
MANAGEMENT'S DISCUSSION AND ANALYSIS 
GENERAL 
1 . This Statement sets for th attestat ion standards and provides guidance to a practit ioner 
concerning the performance of an attest engagement1 w i t h respect to management 's discussion 
and analysis (MD&A) prepared pursuant to the published rules and regulations of the Securities and 
Exchange Commission (SEC), wh ich are presented in annual reports to shareholders and in other 
documents . 2 The presentation of M D & A const i tutes a wr i t ten assertion upon wh ich an attest 
engagement may be performed. 
Applicability 
2. This Statement is applicable to the fo l lowing levels of service when a practit ioner is engaged 
by (a) a public ent i ty that prepares M D & A in accordance w i th the published SEC rules and 
regulations3 or (b) a nonpublic entity that prepares an M D & A presentation and whose management 
provides a wri t ten assertion that the presentation has been prepared using the published SEC rules 
and regulat ions:4 
• An examination of an M D & A presentation 
• A review of an M D & A presentation for an annual or interim period 
1Paragraph 1 of Statement on Standards for Attestation Engagements (SSAE) No. 1, Attestation 
Standards (AICPA, Professional Standards, vol. 1, AT sec. 100), defines an attest engagement as "one in 
which a practitioner is engaged to issue or does issue a written communication that expresses a conclusion 
about the reliability of a written assertion that is the responsibility of another party." 
2 
Because this Statement provides guidance specific to attest engagements concerning MD&A 
presentations, a practitioner should not perform a compliance attestation engagement under SSAE No. 3, 
Compliance Attestation (AICPA, Professional Standards, vol. 1, AT sec. 500), with respect to an MD&A 
presentation. 
3The published requirements for MD&A have changed periodically since the first requirement was 
adopted by the SEC in 1974. As of the date of issuance of this Standard, the published SEC rules and 
regulations for MD&A are found in Item 303 of Regulation S-K, as amended by Financial Reporting Release 
(FRR) No. 36, Management's Discussion and Analysis of Financial Condition and Results of Operations; 
Certain Investment Company Disclosures. Item 303 of Regulation S-K, as amended by FRR No. 36, provides 
the relevant published SEC rules and regulations that meet the definition of reasonable criteria in paragraphs 
11 through 17 of SSAE No. 1. The practitioner should consider whether the SEC has published additional 
rules and regulations with respect to MD&A subsequent to the issuance of this Statement. 
4Such assertion may be made by including either (a) a statement in the body of the MD&A 
presentation that it has been prepared using the published SEC rules and regulations or (b) a separate written 
assertion accompanying the MD&A presentation. 
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A practit ioner5 engaged to examine or review M D & A and report thereon should comply w i t h the 
general, f ieldwork, and reporting standards in Statement on Standards for At testat ion Engagements 
(SSAE) No. 1 Attestation Standards (AICPA, Professional Standards, vo l . 1 , AT sec. 100), and the 
speci f ic standards set for th in this Statement. A practit ioner engaged to perform agreed-upon 
procedures on MD&A should fol low the guidance set forth in SSAE No. 4 , Agreed-Upon Procedures 
Engagements (AICPA, Professional Standards, vol . 1 , AT sec. 600) , or SAS No. 75 , Engagements 
to Apply Agreed-Upon Procedures to Specified Elements, Accounts, or Items of a Financial 
Statement (AICPA, Professional Standards, vo l . 1 , AU sec. 622) . 6 
3. This Statement does not— 
a. Change the auditor 's responsibil ity in an audit of f inancial s tatements performed in 
accordance w i th generally accepted audit ing standards (GAAS). 
b. Apply to situations in wh ich the practit ioner is requested to provide management w i th 
recommendat ions to improve the M D & A and not to provide assurance. A practit ioner 
engaged to provide such nonattest services should refer to the guidance in the Statement 
on Standards for Consult ing Services, Consulting Services: Definitions and Standards 
(AICPA, Professional Standards, vo l . 2, CS sec. 100). 
c. Apply to situations in wh ich the practit ioner is engaged to provide attest services w i th 
respect to an M D & A presentation that is prepared based on criteria other than the 
publ ished SEC rules and regulations for M D & A . A practit ioner engaged to provide such 
attest services should refer to the guidance in SSAE No. 1 , SSAE No. 4 , or SAS No. 75 . 7 
5In this Standard, the terms practitioner or accountant generally refer to a person engaged to 
perform an attest service on MD&A. The term auditor refers to a person engaged to audit financial 
statements. As this Standard includes certain requirements for the practitioner to have audited or performed 
a SAS No. 71 review of financial statements (Interim Financial Information, AICPA, Professional Standards, 
vol . 1, sec. 722), the terms auditor, practitioner or accountant may refer, in this Standard, to the same 
person. 
6Practitioners should follow guidance in SAS No. 72, Letters for Underwriters and Certain Other 
Requesting Parties, as amended by SAS No. 76 and SAS No. XX, when requested to perform agreed-upon 
procedures on MD&A and report thereon in a letter for an underwriter (see AICPA, Professional Standards, 
vol. 1, AU sec. 634). 
7The guidance in this Standard may be helpful when performing an engagement to provide attest 
services with respect to an MD&A presentation that is based on criteria other than the published SEC rules 
and regulations for MD&A. 
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Conditions for Engagement Performance 
Examination 
4 . The pract i t ioner 's objective in an engagement to examine M D & A is to express an opinion on 
the M D & A presentation taken as a whole by report ing whether (a) the presentation includes the 
required elements of Item 303 of Regulation S-K and the related published SEC rules and 
regulat ions,8 (b) the historical f inancial amounts have been accurately derived f rom the ent i ty 's 
financial statements,9 and (c) the underlying information and assumptions of the ent i ty provide a 
reasonable basis for the disclosures contained therein. 
5. A practitioner may accept an engagement to examine the MD&A of a public or nonpublic ent i ty, 
provided the practitioner audits, in accordance w i t h GAAS, 1 0 the financial s tatements for at least 
the latest period to wh ich the M D & A relates. A base knowledge of t h e ent i ty and its operations 
gained th rough an audit of the historical financial statements is necessary to provide the 
practitioner w i th sufficient knowledge to properly evaluate the results of the procedures performed 
in connect ion w i th the examinat ion. In determining whether to accept an engagement, the 
pract i t ioner should also consider whether management (and others engaged by management to 
assist them, such as legal counsel) has the appropriate knowledge of the published SEC rules and 
regulations to prepare M D & A . 
6. The practitioner should not accept an engagement to examine M D & A of a public or nonpublic 
entity unless the financial s tatements for the respective periods covered by the M D & A have been 
audited. 
7. When a predecessor auditor has audited the financial statements for a prior period covered by 
the MD&A but has not examined the M D & A for that period, the practit ioner should also consider 
whe the r , under the particular c i rcumstances, he or she can acquire suff ic ient knowledge of the 
business and of the ent i ty 's account ing and financial report ing practices for such period so tha t 
he or she wou ld be able t o : 
8The required elements as of the date of issuance of this Standard include a discussion of the 
entity's financial condition, changes in financial condition, and results of operations, including a discussion 
of liquidity and capital resources. 
9Whether historical financial amounts are accurately derived from the financial statements includes 
both amounts that are derived from the face of the financial statements (which includes the notes to the 
financial statements) and those that are derived from underlying records supporting elements, accounts, or 
items included in the financial statements. 
10Restrictions on the scope of the audit of the financial statements will not necessarily preclude the 
practitioner from accepting an engagement to examine the MD&A. The practitioner should consider the 
nature and magnitude of the scope limitation and the form of the auditor's report in assessing whether an 
examination of MD&A could be performed. 
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a. Identify types of potential material misstatements in the MD&A and consider the likelihood 
of their occurrence. 
b. Perform the procedures that will provide the practitioner with a basis for expressing an 
opinion on the MD&A with respect to whether the historical financial amounts have been 
accurately derived from the entity's financial statements for such period. 
c. Perform the procedures that will provide the practitioner with a basis for expressing an 
opinion as to whether the underlying information and assumptions of the entity provide a 
reasonable basis for the disclosures contained therein. 
8. Review. The objective of a review of MD&A is to accumulate sufficient evidence to limit 
attestation risk to a moderate level to provide the practitioner with a basis for reporting whether 
any information came to the practitioner's attention to cause him or her to believe that (a) the 
MD&A does not include the required elements of Item 303 of Regulation S-K and the related 
published SEC rules and regulations, (b) the historical financial amounts included therein have not 
been accurately derived from the entity's financial statements, or (c) the underlying information 
and assumptions of the entity do not provide a reasonable basis for the disclosures contained 
therein. A review consists principally of applying analytical procedures and making inquiries of 
persons responsible for financial, accounting and operational matters. A review does not 
contemplate (a) tests of accounting records through inspection, observation, or confirmation, (b) 
obtaining corroborating evidential matter in response to inquiries, or (c) the application of certain 
other procedures ordinarily performed during an examination of MD&A. A review may bring to the 
practitioner's attention significant matters affecting the MD&A, but it does not provide assurance 
that the practitioner will become aware of all significant matters that would be disclosed in an 
examination. 
9. In determining whether to accept an engagement, the practitioner should consider whether 
management (and others engaged by management to assist them, such as legal counsel) has the 
appropriate knowledge of the published SEC rules and regulations to prepare MD&A. 
10. A practitioner may accept an engagement to review the MD&A presentation of a public entity 
for an annual period provided the practitioner has audited, in accordance with GAAS, the financial 
statements for at least the latest year to which the MD&A relates. A base knowledge of the entity 
and its operations gained through an audit of the historical financial statements is necessary to 
provide the practitioner with sufficient knowledge to properly evaluate the results of the 
procedures performed in connection with the review. 
11. When a predecessor auditor has audited the financial statements for a prior period covered 
by the MD&A but has not examined or reviewed the MD&A for that period, the practitioner should 
also consider whether, under the particular circumstances, he or she can acquire sufficient 
knowledge of the business and of the entity's accounting and financial reporting practices for such 
period so he or she would be able to — 
a. Identify types of potential material misstatements in the MD&A and consider the likelihood 
of their occurrence. 
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b. Perform the procedures that will provide the practitioner with a basis for reporting whether 
any information has come to the practitioner's attention to cause him or her to believe that 
(1) the MD&A does not include the required elements of Item 303 of Regulation S-K and 
the related published SEC rules and regulations, (2) the historical financial amounts included 
therein have not been accurately derived from the entity's financial statements for such 
period, or (3) the underlying information and assumptions of the entity do not provide a 
reasonable basis for the disclosures contained therein. 
12. A practitioner may accept an engagement to review the MD&A presentation of a public entity 
for an interim period provided that both of the following conditions are met: 
a. The practitioner performs either (1) a SAS No. 71 review of the historical financial 
statements for the related interim periods and issues a review report thereon, or ( i ) an 
audit of the interim financial statements 
b. The MD&A presentation for the most recent fiscal year has been or will be examined or 
reviewed 
13. If a predecessor practitioner examined or reviewed the MD&A presentation of a public entity 
for the most recent fiscal year, the practitioner should not accept an engagement to review the 
MD&A presentation for an interim period unless he or she can acquire sufficient knowledge of the 
business and of the entity's accounting and financial reporting practices for the interim period to 
perform the procedures described in paragraph 11 . 
14. If a nonpublic entity chooses to prepare MD&A, the practitioner should not accept an 
engagement to perform a review of such MD&A for an annual period under this Statement unless 
both of the following conditions are met: (a) The annual financial statements for the periods 
covered by the MD&A have been or will be audited and the practitioner has audited or will audit 
the most recent year (refer to paragraph 7 if the financial statements for prior years were audited 
by a predecessor accountant) and (b) management will provide a written assertion that the 
presentation has been prepared using the published SEC rules and regulations as the criteria (see 
paragraph 2). 
15. A practitioner may accept an engagement to review the MD&A presentation of a nonpublic 
entity for an interim period provided that all of the following conditions are met: 
a. The practitioner performs either (1) a review of the historical financial statements for the 
related interim periods under the Statement on Standards for Accounting and Review 
Services and issues a review report thereon, or (2) an audit of the interim financial 
statements 
b. The MD&A presentation for the most recent fiscal year has been or will be examined or 
reviewed 
c. Management will provide a written assertion stating that the presentation has been 
prepared using the published SEC rules and regulations as the criteria (see paragraph 2) 
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Responsibilities of Management 
16. Management is responsible for the preparation of the ent i ty 's M D & A pursuant to Item 303 
of Regulat ion S-K and the related published SEC rules and regulations. The preparation of the 
M D & A in conformi ty w i t h the published SEC rules and regulations requires management to 
interpret the criteria, make determinations as to the relevancy of information to be included, and 
make estimates and assumptions that af fect reported informat ion. 
17. An entity should not name the practitioner in a client-prepared document as having examined 
or reviewed the M D & A unless the M D & A presentation and related pract i t ioner 's report and the 
related financial s tatements and auditor 's (or accountant 's review) report are included in the 
document (or, in the case of a public ent i ty , incorporated by reference to such informat ion filed 
w i th a regulatory agency). If such a statement is made in a document tha t does not include (or 
incorporate by reference) such informat ion the practit ioner should request that neither his or her 
name nor reference to the practit ioner be made w i th respect to the M D & A informat ion, or that 
such document be revised to include the required presentations and reports. If the client does not 
comply, the practitioner should advise the client that he or she does not consent to either the use 
of his or her name or the reference to the practit ioner, and he or she should consider wha t other 
actions might be appropriate.11 
Obtaining an Understanding of the SEC Rules and Regulations and Management's Methodology for 
the Preparation of MD&A 
18. The practit ioner should obtain an understanding of the published SEC rules and regulations 
for M D & A , including Item 303 of Regulation S-K and any Interpretative Releases.12 
19. The practitioner should inquire of management regarding the method of preparing the M D & A , 
including matters such as the sources of the informat ion, how the informat ion is gathered, how 
management evaluates the types of factors having a material ef fect on financial condit ion 
(including liquidity and capital resources), results of operations, and cash f l ows , and whether there 
have been any changes in the procedures f rom the prior year. 
Timing of Procedures 
20. Proper planning by the practit ioner contr ibutes to the effect iveness of the attest procedures 
in an examinat ion or a review of M D & A . Performing some of the wo rk in conjunct ion w i th the 
audit of the historical financial statements or the review of interim financial statements may permit 
the work to be carried out in a more efficient manner and to be completed at an earlier date. When 
performing an examination or review of M D & A , the practit ioner may consider the results of tests 
11In considering what other actions, if any, may be appropriate in these circumstances, the 
practitioner may wish to consult his or her legal counsel. 
12
 See footnote 3 to paragraph 2. 
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of controls, analytical procedures, and substantive tests performed in a financial statement audit 
or analytical procedures and inquiries made in a review of interim financial information. 
Materiality 
2 1 . The practitioner should consider the concept of materiality in planning and performing the 
engagement. The objective of an examination or a review is to report on the MD&A presentation 
taken as a whole and not on the individual amounts and disclosures contained therein. Assessing 
the significance of a misstatement of some items in MD&A may be more dependent upon 
qualitative than quantitative considerations (for example, in assessing whether the underlying 
information and assumptions of the entity provide a reasonable basis for the disclosures in the 
MD&A). Materiality is also a concept that is judged in light of the expected range of 
reasonableness of the information; therefore, users should not expect prospective information 
(information about events that have not yet occurred) to be as precise as historical information. 
22. For the purpose of assessing whether particular measurement and disclosure criteria can be 
expected to yield reasonably consistent estimates or measurements, materiality should be judged 
in light of the expected range of reasonableness for a particular assertion. 
23. In expressing a conclusion, or providing the limited assurance of a review engagement, on the 
conformity of the presentation with the published rules and regulations of the SEC, the practitioner 
should consider the omission or misstatement of an individual assertion to be material if the 
magnitude of the omission or misstatement—individually or when aggregated with other omissions 
or misstatements —is such that a reasonable person relying on the MD&A presentation would be 
influenced by the inclusion or correction of the individual assertion. The relative, rather than 
absolute, size of an omission or misstatement may determine whether it is material in a given 
situation. 
Inclusion of Pro Forma Financial Information 
24. Management may include pro forma financial information with respect to a business 
combination or other transactions in the MD&A. The practitioner should consider the guidance in 
SSAE No. 1, AT section 300, "Reporting on Pro Forma Financial Information," paragraph 10 
(AICPA, Professional Standards, vol. 1, AT sec. 300) when performing procedures with respect 
to such information, even if management indicates in the MD&A that certain information has been 
derived from unaudited financial statements. For example, in an examination of MD&A the 
practitioner's procedures would ordinarily include obtaining an understanding of the underlying 
transaction or event, discussing with management their assumptions, obtaining sufficient evidence 
in support of the adjustments, and other procedures for the purpose of expressing an opinion on 
the MD&A presentation taken as a whole and not for expressing an opinion on (or providing the 
limited assurance of a review of) the pro forma financial information included therein under SSAE 
No. 1, section 300. 
Inclusion of External Information 
25. An entity may also include in its MD&A information external to the entity, such as the rating 
of its debt by certain rating agencies or comparisons with statistics from a trade association. Such 
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external informat ion should also be subjected to the pract i t ioner 's examination or review 
procedures. For example, in an examination the practitioner might compare information concerning 
s ta t i s t i cs of a trade organization to a published source; however, the practit ioner wou ld not be 
expected to test the underlying support for the trade associat ion's calculation of such stat ist ics. 
Inclusion of Forward-Looking or Voluntary Information 
26. An ent i ty may include certain forward- looking disclosures or may voluntari ly include other 
information in the M D & A presentation that is not required by the published rules and regulations 
of the SEC. Although any forward- looking or voluntary informat ion that is included in the M D & A 
presentation should be subjected to the pract i t ioner's examination or review, such informat ion is 
subjected to test ing only for the purpose of expressing an opinion or providing the limited 
assurance of a review on the M D & A presentation taken as a whole . 
EXAMINATION ENGAGEMENT 
27. To express an opinion about whether (a) the presentation includes the required elements of 
Item 303 of Regulation S-K and the related published SEC rules and regulations, (b) the historical 
financial amounts have been accurately derived f rom the ent i ty 's financial s tatements, and (c) the 
underlying information and assumptions of the entity provide a reasonable basis for the disclosures 
contained therein, the practitioner seeks to obtain reasonable assurance by accumulat ing suff ic ient 
evidence in support of the disclosures and assumptions, thereby l imiting at testat ion risk to an 
appropriately low level. 
Attestation Risk 
28. In an engagement to examine M D & A , the practit ioner plans and performs the examination to 
obtain reasonable assurance of detecting both intentional and unintentional misstatements that are 
material to the M D & A presentation taken as a whole . Absolute assurance is not attainable 
because of factors such as the need for judgment regarding the areas to be tested and the nature, 
t iming, and extent of tests to be performed; the concept of selective test ing of the data; and the 
inherent l imitat ions of the controls applicable to the preparation of M D & A . The practit ioner 
exercises professional judgment in assessing the significant assumptions and determinations made 
by management as to the relevancy of informat ion. As a result of these factors, in the great 
majority of cases, the practitioner has to rely on evidence that is persuasive rather than convincing. 
A lso, procedures may be ineffect ive for detect ing an intentional misstatement that is concealed 
through collusion among client personnel and third parties or among management or employees 
of the client. Therefore, the subsequent discovery that a material misstatement exists in the 
MD&A does not, in and of itself, evidence (a) failure to obtain reasonable assurance, (b) inadequate 
p lann ing , per formance, or judgment on the part of the practit ioner, (c) the absence of due 
professional care, or (d) a failure to comply w i t h this Standard. 
29. Factors to be considered by the practit ioner in planning an examinat ion of M D & A include (a) 
the anticipated level of at testat ion risk related to assertions embodied in the M D & A presentat ion, 
(b) preliminary judgments about materiality levels for at test purposes, (c) the items wi th in the 
MD&A presentation that are likely to require revision or adjustment, and (d) condit ions that may 
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require extension or modification of attest procedures. For purposes of an engagement to examine 
MD&A, the components of attestation risk are defined as follows: 
a. Inherent risk —the susceptibility of an assertion (see paragraphs 33 through 36) within 
MD&A to a material misstatement, assuming that there are no related controls. 
b. Control risk—the risk that a material misstatement that could occur in an assertion within 
MD&A will not be prevented or detected on a timely basis by the entity's controls. Some 
control risk will always exist because of the inherent limitations of any internal control. 
c. Detection risk—The risk that the practitioner will not detect a material misstatement that 
exists in an assertion within MD&A. 
30. Inherent Risk. The level of inherent risk varies with the nature of the assertion. For example, 
the inherent risk concerning financial information included in the MD&A presentation may be low, 
whereas the inherent risk concerning the completeness of the disclosure of the entity's risks or 
liquidity may be high. 
3 1 . Control Risk. The practitioner should assess control risk as discussed in paragraphs 51 
through 55. Assessing control risk contributes to the practitioner's evaluation of the risk that 
material misstatement in the MD&A exists. In the process of assessing control risk (together with 
assessing inherent risk), the practitioner may obtain evidential matter about the risk that such 
misstatement may exist. The practitioner uses this evidential matter as part of the reasonable 
basis for his or her opinion on the MD&A presentation taken as a whole. 
32. Detection Risk. In determining an acceptable level of detection risk, the practitioner assesses 
inherent risk and control risk and considers the extent to which he or she seeks to restrict 
attestation risk. As assessed inherent risk or control risk decreases, the acceptable level of 
detection risk increases. Accordingly, the practitioner may alter the nature, timing, and extent of 
tests performed based on the assessments of inherent risk and control risk. 
Nature of Assertions 
33. Assertions are representations by management that are embodied in the MD&A presentation. 
They can be either explicit or implicit and can be classified according to the following broad 
categories: 
a. Occurrence 
b. Consistency with the financial statements 
c. Completeness 
34. Assertions about occurrence address whether reported transactions or events have occurred 
during a given period. Assertions about consistency with the financial statements address whether 
reported transactions, events, and explanations are consistent with the financial statements, 
whether historical financial amounts have been accurately derived from the financial statements 
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and related records, and whether nonfinancial data have been accurately derived f rom related 
records. 
35. Assertions about completeness address whether transact ions and events necessary to obtain 
an understanding of the ent i ty 's f inancial condi t ion, changes in financial condi t ion, results of 
operat ions, and material commi tments for capital resources are included in the M D & A ; and 
whether known events, transactions, condit ions, t rends, demands, commi tments , or uncertainties 
that wil l result in, or are reasonably likely to result in, material changes are described in the M D & A 
presentat ion. 
36. For example, when management asserts that the reason for an increase in revenues is a price 
increase in the current year, they are explicit ly asserting that both an increase in revenues and a 
price increase have occurred in the current year, and implicitly asserting that any historical f inancial 
amounts included are consistent w i t h the financial statements for such period. They are also 
implicitly asserting that the explanation for the increase in revenues is complete; that there are no 
other signif icant reasons for the increase in revenues. 
37. The auditor of the underlying financial statements is responsible for obtaining and evaluating 
evidential matter concerning the assertions embodied in the account balance or t ransact ion class 
of the financial s tatements as discussed in SAS No. 3 1 , Evidential Matter, as amended (AICPA, 
Professional Standards, vol . 1 , AU sec. 326). Although tests designed to achieve the pract i t ioner 's 
ob jec t ive of forming an opinion on the M D & A presentation taken as a whole may test certain 
assertions embodied in the underlying financial statements, the practit ioner is not expected to test 
the underlying financial s tatement assertions in an examinat ion of M D & A . For example, the 
practit ioner is not expected to test the completeness of revenues or the existence of inventory 
when test ing the assertions in M D & A concerning an increase in revenues or an increase in 
inventory levels; however, the practit ioner is responsible for test ing the completeness of the 
explanation for the increase in revenues or the increase in inventory levels. 
Performing an Examination Engagement 
3 8 . The practit ioner should exercise (a) due care in planning, performing, and evaluating the 
results of his or her examination procedures, and (b) the proper degree of professional skept icism 
to obtain reasonable assurance that material misstatement wi l l be detected. 
39 . In an examination of M D & A , the practit ioner should — 
a. Obta in an understanding of the published SEC rules and regulations for M D & A and 
management 's method of preparing M D & A (paragraphs 18 and 19). 
b. Plan the engagement (paragraphs 4 0 through 46) . 
c. Consider relevant port ions of the ent i ty 's internal control applicable to the preparation of 
M D & A (paragraphs 47 through 56). 
d. Obtain suff ic ient evidence, including test ing completeness (paragraphs 57 through 62) . 
e. Consider events subsequent to the balance-sheet date (paragraphs 63 and 64) . 
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f. Obtain written representations from management concerning its responsibility for the 
MD&A, completeness of minutes, events subsequent to the balance-sheet date, and other 
matters about which the practitioner believes written representations are appropriate 
(paragraph 114). 
g. Form an opinion about whether the MD&A includes, in all material respects, the required 
elements of Item 303 of Regulation S-K and the related published SEC rules and 
regulations, whether the historical financial amounts included therein have been accurately 
derived, in all material respects, from the entity's financial statements, and whether the 
underlying information and assumptions of the entity provide a reasonable basis f o r the 
disclosures contained in the MD&A (paragraph 65). 
Planning the Engagement 
40. General Considerations. Planning an engagement to examine MD&A involves developing an 
overall strategy for the expected scope and performance of the engagement. When developing 
an overall strategy for the engagement, the practitioner should consider factors such as the 
following: 
• Matters affecting the industry in which the entity operates, such as financial reporting 
practices, economic conditions, laws and regulations, and technological changes 
• Knowledge of the entity's internal control applicable to the preparation of MD&A obtained 
during the audit of the financial statements and the extent of recent changes, if any 
• Matters relating to the entity's business, including its organization, operating 
characteristics, capital structure, and distribution methods 
• The types of relevant information that management reports to external analysts (for 
example, press releases and presentations to lenders and rating agencies, if any, 
concerning past and future performance) 
• How the entity analyzes actual performance compared to budgets and the types of 
information provided in documents submitted to the board of directors for purposes of the 
entity's day-to-day operations and long-range planning 
• The extent of management's knowledge of and experience with the published SEC rules 
and regulations 
• If the entity is a nonpublic entity, the intended use of the MD&A presentation 
• Preliminary judgments about (a) materiality, (b) inherent risk at the individual assertion level, 
and (c) factors (for example, matters identified during the audit or review of the historical 
financial statements) relating to significant deficiencies in internal control applicable to the 
preparation of MD&A (see paragraph 56). 
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• The type and extent of evidential matter support ing management 's assertions and 
disclosures in the M D & A 
• The nature of complex or subjective matters potential ly material to the M D & A tha t may 
require special skill or knowledge and whether such matters may require using the work 
of a specialist to obtain suff ic ient evidential matter (see paragraph 45) 
• The presence of an internal audit funct ion (see paragraph 46) . 
4 1 . In planning an engagement when M D & A has not previously been examined, the practit ioner 
should consider the degree to which the entity has information available for such prior periods and 
the continuity of the enti ty 's personnel and their ability to respond to inquiries w i th respect to such 
periods. In addition, the practitioner should obtain an understanding of the ent i ty 's internal control 
in prior years applicable to the preparation of the M D & A . 
42 . Consideration of Audit Results. The practitioner should also consider the results of the audits 
of the financial statements for the periods covered by the M D & A on the examinat ion engagement, 
such as matters relating to the fo l lowing: 
• The availability and condit ion of the ent i ty 's records 
• The nature and magnitude of audit adjustments 
• Likely misstatements13 that were not corrected in the financial s tatements that may affect 
MD&A disclosures (for example, misclassifications between financial s tatement line items) 
4 3 . The practit ioner should also consider the possible impact on the scope of the examination 
engagement of any modi f icat ion, or contemplated modi f icat ion, of the auditor 's report, including 
matters addressed in explanatory language. 
44. Multiple Components. In an engagement to examine M D & A when the ent i ty has operations 
in several components (for example, locations, branches, subsidiaries, or programs), the 
practitioner should determine the components to wh ich procedures should be applied. In making 
such a determination and in selecting the components to be tested, the accountant should consider 
factors such as the fo l lowing: 
• The relative importance of each component to the applicable M D & A disclosure 
• The degree of centralization of records 
• The effect iveness of controls, particularly those that af fect management 's direct control 
over the exercise of authori ty delegated t o others and its ability t o supervise activit ies at 
various locations effect ively 
13Refer to paragraphs 27 through 32 of SAS No. 47, Audit Risk and Materiality in Conducting an 
Audit (AICPA, Professional Standards, vol. 1, AU sec. 312). 
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• The nature and extent of operations conducted at the various components, and 
• The similarity of operations and internal control for different components 
45. Using the Work of a Specialist. In some engagements to examine MD&A, the nature of 
complex or subjective matters potentially material to the MD&A may require specialized skill or 
knowledge in a particular field other than accounting or auditing. For example, the entity may 
include information concerning plant production capacity, which would ordinarily be determined 
by an engineer. In such cases, the practitioner may use the work of a specialist and should 
consider the relevant guidance in SAS No. 73, Using the Work of a Specialist (AICPA, Professional 
Standards, vol. 1, AU sec. 336). SAS Ho. 22, Planning and Supervision (AICPA, Professional 
Standards, vol. 1, AU sec. 311) provides relevant guidance for situations in which a specialist 
employed by the practitioner's firm participates in the examination. 
46. Internal Audit Function. Another factor the practitioner should consider when planning the 
engagement is whether the entity has an internal audit function and the extent to which internal 
auditors are involved in directly testing the MD&A presentation, in monitoring the entity's internal 
control applicable to the preparation of MD&A, or in testing the underlying records supporting 
disclosures in the MD&A. A practitioner should consider the guidance in SAS No. 65, The 
Auditor's Consideration of the Internal Audit Function in an Audit of Financial Statements (AICPA, 
Professional Standards, vol. 1, AU sec. 322), when addressing the competence and objectivity of 
internal auditors, the nature, timing, and extent of work to be performed, and other related 
matters. 
Consideration of Internal Control Applicable to the Preparation of MD&A 
47. The practitioner should obtain an understanding of the entity's internal control applicable to 
the preparation of MD&A sufficient to plan the engagement and to assess control risk. Generally, 
controls that are relevant to an examination pertain to the entity's objective of preparing MD&A 
in conformity with the published SEC rules and regulations, and may include controls within the 
control environment, risk assessment, control activities, information and communication, and 
monitoring components. 
48. The controls relating to operations and compliance objectives may be relevant to an 
examination if they pertain to data the practitioner evaluates or uses in applying examination 
procedures. For example, controls relating to nonfinancial data that are included in the MD&A 
presentation may be relevant to an examination engagement. 
49. In planning the examination, knowledge of such controls should be used to identify types of 
potential misstatement (including types of potential material omissions), to consider factors that 
affect the risk of material misstatement, and to design appropriate tests. 
50. A practitioner generally obtains an understanding of the design of the entity's internal control 
applicable to the preparation of MD&A by making inquiries of appropriate management, 
supervisory, and staff personnel; by inspection of the entity's documents; and by observation of 
the entity's relevant activities, including controls over matters discussed, nonfinancial data 
included, and management evaluation of the reasonableness of information included. The nature 
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and extent of procedures a practit ioner performs vary f rom ent i ty to ent i ty and are influenced by 
factors such as the ent i ty 's complexi ty , the length of t ime tha t the enti ty has been subject to the 
requirements of Item 303 of Regulation S-K, the pract i t ioner 's knowledge of the ent i ty 's controls 
obtained in audits and previous professional engagements, and judgments about material i ty. 
5 1 . After obtaining an understanding of the ent i ty 's internal control applicable to the preparation 
of M D & A , the practit ioner assesses control risk for the assertions embodied in the M D & A 
presentation (refer to paragraphs 33 through 37). The practit ioner may assess control risk at the 
max imum level (the greatest probabil i ty that a material misstatement that could occur in an 
assertion wil l not be prevented or detected on a t imely basis by an ent i ty 's controls) because the 
practitioner believes controls are unlikely to pertain to an assert ion, are unlikely to be ef fect ive, or 
because evaluating their effect iveness wou ld be ineff icient. Alternat ively, the practit ioner may 
obtain evidential matter about the effectiveness of both the design and operation of a control that 
supports a lower assessed level of control risk. Such evidential matter may be obta ined f rom tests 
of controls planned and performed concurrently w i t h obtaining the understanding or f rom 
procedures performed to obtain the understanding that were not specifically planned as tests of 
controls. 
52. Af ter obtaining the understanding and assessing control risk, the practit ioner may desire to 
seek a further reduction in the assessed level of control risk for certain assertions. In such cases, 
the practit ioner considers whether evidential matter suff ic ient to support a further reduction is 
likely to be available and whether performing additional tests of controls to obtain such evidential 
matter wou ld be eff icient. 
53 . When seeking to assess control risk below the max imum for controls over financial and 
nonfinancial data, the practit ioner should perform tests of controls to obtain evidence to support 
the assessed level of control risk. For example, the practit ioner may perform tests of controls 
d i rected toward the effect iveness of the design or operation of internal control over the 
accumulation of number of units sold for a manufactur ing company, average interest rates earned 
and paid for a financial inst i tut ion, or average net sales per square foo t for a retail ent i ty . 
5 4 . The practit ioner uses the knowledge provided by the understanding of internal control 
applicable to the preparation of M D & A and the assessed level of control risk in determining the 
nature, t im ing, and extent of substant ive tests for the M D & A assertions. 
55 . The practit ioner should document the understanding of the internal control components 
obtained to plan the examination and the assessment of control risk. The fo rm and extent of this 
documentation is influenced by the size and complexi ty of the ent i ty , as wel l as the nature of the 
ent i ty 's controls applicable to the preparation of M D & A . 
56. During the course of an engagement to examine M D & A , the practit ioner may become aware 
of significant deficiencies in the design or operation of internal control applicable to the preparation 
of MD&A that could adversely affect the ent i ty 's ability to prepare M D & A in accordance w i th the 
published SEC rules and regulations. The practit ioner should consider the implications of such 
cont ro l deficiencies on the his or her ability to rely on management 's explanations and on 
comparisons to summary accounting records. A practitioner's responsibil ity to communicate these 
control deficiencies in an examination of M D & A is similar to the auditor 's responsibil ity described 
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in SAS No. 60, Communication of Internal Control Related Matters Noted in an Audit, and SAS No. 
61 , Communication With Audit Committees (AICPA, Professional Standards, vol. 1, AU secs. 325 
and 380, respectively). 
Obtaining Sufficient Evidence 
57. The practitioner should apply procedures to obtain reasonable assurance of detecting material 
misstatements. In an audit of historical financial statements, the practitioner will have applied 
audit procedures to some of the information included in the MD&A. However, because the 
objective of those audit procedures is to have a reasonable basis for expressing an opinion on the 
basic financial statements taken as a whole rather than on the MD&A, certain additional 
examination procedures should be performed. Determining these procedures and evaluating the 
sufficiency of the evidence obtained are matters of professional judgment. 
58. The practitioner ordinarily should apply the following procedures: 
a. Read the MD&A and compare the content for consistency with the audited financial 
statements or related accounting records and analyses; recompute increases, decreases, 
and percentages disclosed. 
b. Compare nonfinancial amounts to the audited financial statements, if applicable, or to other 
records (refer to paragraphs 60 through 62). 
c. Consider whether explanations are consistent with information obtained during the audit; 
investigate further those explanations that cannot be substantiated by information in the 
audit working papers through inquiry (including inquiry of officers and other executives 
having responsibility for operational areas) and inspection of client records. 
d. Examine internally generated documents (for example, variance analyses, sales analyses, 
wage cost analyses, sales or service pricing sheets, and business plans or programs) and 
externally generated documents (for example, correspondence, contracts, or loan 
agreements) in support of the existence, occurrence, or expected occurrence of events, 
transactions, conditions, trends, demands, commitments, and uncertainties disclosed in the 
MD&A.. 
e. Obtain available prospective financial information (for example, budgets; sales forecasts; 
forecasts of labor, overhead, and materials costs; capital expenditure requests; and 
financial forecasts and projections) and compare such information to forward-looking 
MD&A disclosures. Consider whether the underlying information and assumptions of the 
entity provide a reasonable basis for the MD&A disclosures of events, transactions, 
conditions, trends, demands, commitments, or uncertainties. 
f. Consider obtaining available prospective financial information relating to prior periods and 
comparing actual results with forecasted and projected amounts. 
g. Make inquiries of officers and other executives having responsibility for operational areas 
(such as sales, marketing, and production) and financial and accounting matters, as to their 
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plans and expectations for the future that could affect the entity's liquidity and capital 
resources. 
h. Consider obtaining external information concerning industry trends, inflation and changing 
prices and comparing the related MD&A disclosures to such information. 
i. Compare the information in the MD&A with the published SEC rules and regulations. 
j . Read the minutes of meetings, to date, of the board of directors and other significant 
committees to identify matters that may affect MD&A; consider whether such matters are 
appropriately addressed in the MD&A. 
k. Inquire of officers as to the entity's prior experience with the SEC and the, extent of 
comments received upon review of documents by the SEC; read correspondence between 
the entity and the SEC with respect to such review, if any. 
I. Obtain public communications (for example, press releases and quarterly reports) dealing 
wi th historical and future results; consider whether the MD&A is consistent with such 
communications. 
59. Testing Completeness. The practitioner should design procedures to test the presentation for 
completeness. The practitioner should consider whether the MD&A discloses matters that could 
significantly impact future financial condition and results of operations of the entity by considering 
information that he or she obtained through the audit of the financial statements; inquiries of the 
entity's officers and other executives directed to current events, conditions, economic changes, 
commitments and uncertainties, within both the entity and its industry; and other information 
obtained through procedures such as those listed in paragraphs 58, 63 and 64. As discussed in 
paragraph 30, the inherent risk concerning the completeness of disclosures may be high; if it is, 
the practitioner may extend the procedures (for example, by making additional inquiries of 
management or by examining additional internally generated documents). 
60. Nonfinancial Data. Management may include nonfinancial data (such as units produced; the 
number of units sold, acquisitions, locations, or customers; plant utilization; or square footage) in 
the MD&A. The practitioner should consider whether the definitions used by management for such 
nonfinancial data are reasonable for the particular disclosure in the MD&A and whether there are 
reasonable criteria that have the characteristics of both relevance and reliability (for example, 
industry standards with respect to square footage for retail operations), as discussed in paragraphs 
15 and 16 of SSAE No. 1. 
61. In some situations, the nonfinancial data or the controls over the nonfinancial data may have 
been tested by the practitioner in conjunction with the financial statement audit; however, the 
practitioner's consideration of the nature of the procedures to apply to nonfinancial data in an 
examination of MD&A is based on the concept of materiality with respect to the MD&A 
presentation. The practitioner should consider whether industry standards exist for the 
nonfinancial data or whether there are different methods of measurement that may be used, and, 
if such methods could result in significantly different results, whether the method of measurement 
selected by management is reasonable and consistent between periods covered by the MD&A 
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presentat ion. For example, the number of customers reported by management could vary 
depending on whether management defines a customer as a subsidiary or "ship t o " location of a 
company rather than the company itself. 
62. In testing nonfinancial data included in the MD&A, the practitioner may seek to assess control 
risk below the max imum for controls over such nonfinancial data, as discussed in paragraph 53 . 
The pract i t ioner weighs the increase in ef fort of the examinat ion associated w i t h the additional 
tes ts of controls that is necessary to obtain evidential matter against the resulting decrease in 
examinat ion ef for t associated w i t h the reduced substant ive tests. For those nonfinancial 
assert ions for wh ich the practit ioner performs additional tests of controls, the practit ioner 
determines the assessed level of control risk that the results of those tests wi l l support. This 
assessed level of control risk is used in determining the appropriate detect ion risk to accept for 
those nonfinancial assertions and, accordingly, in determining the nature, t im ing , and extent of 
substant ive tests for such assertions. 
Consideration of Events Subsequent to the Balance-Sheet Date 
63. As there is an expectation by the SEC that M D & A considers events through a date at or near 
the fil ing date,1 4 the practit ioner should consider information about events1 5 tha t comes to his or 
her at tent ion after the end of the period addressed by M D & A and prior to the issuance of his or 
her report that may have a material ef fect on the ent i ty 's operat ions, l iquidity, and capital 
resources. Events or matters that should be disclosed in the M D & A include those that— 1 6 
• Are reasonably expected to have a material favorable or unfavorable impact on net sales 
or revenues or income f rom cont inuing operations. 
• Are reasonably likely to result in the ent i ty 's l iquidity increasing or decreasing in any 
material way . 
• Will have a material ef fect on the ent i ty 's capital resources. 
• W o u l d cause reported financial information not to be necessarily indicative of future 
operating results or of future financial condi t ion. 
The practit ioner should consider whether events identif ied during the examinat ion of the M D & A 
or the audit of the related financial statements require adjustment to or disclosure in the M D & A . 
14A registration statement under the Securities Act of 1933 speaks as of its effective date. 
15Such events are only referred to as "subsequent events" in relation to an MD&A presentation if 
they occur after the MD&A presentation has been issued. The annual MD&A presentation would not be 
updated for subsequent events if an MD&A presentation for a subsequent interim period has been issued or 
the event has been reported through a filing on Form 8-K. 
16The practitioner should refer to the published SEC rules and regulations for other examples of 
events that should be disclosed. 
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Paragraphs 98 through 100 provide guidance when the practitioner is engaged subsequent to the 
filing of the MD&A presentation. 
64. In an examination of MD&A, the practitioner's fieldwork ordinarily extends beyond the date 
of the auditor's report on the related financial statements.17 Accordingly, the practitioner generally 
should — 
a. Read available minutes of meetings of stockholders, the board or directors, and other 
appropriate committees; as to meetings for which minutes are not available, inquire about 
matters dealt with at such meetings. 
b. Read the latest available interim financial statements for periods subsequent to the date of 
the auditor's report, compare them with the financial statements for the periods covered 
by the MD&A, and inquire of and discuss with officers and other executives having 
responsibility for operational, financial, and accounting matters (limited where appropriate 
to major locations) such as — 
• Whether interim financial statements have been prepared on the same basis as the 
audited financial statements. 
• Whether there were any significant changes in the entity's operations, liquidity, or 
capital resources in the subsequent period. 
• The current status of items in the financial statements for which the MD&A has 
been prepared, that were accounted for on the basis of tentative, preliminary or 
inconclusive data. 
• Whether any unusual adjustments were made during the period from the balance 
sheet date to the date of inquiry. 
c. Make inquiries of members of senior management as to the current status of matters 
concerning litigation, claims, and assessments identified during the audit of the financial 
statements and of any new matters or unfavorable developments. Consider obtaining 
updated legal letters from legal counsel. 
d. Obtain written representations from appropriate officials as to whether any events occurred 
subsequent to the latest balance sheet date that would require disclosure in the MD&A (see 
paragraph 114). 
17 
Undertaking an engagement to examine MD&A does not extend the auditor's responsibility to 
update the subsequent events review procedures for the financial statements beyond the date of the 
auditor's report. However, see SAS No. 1, section 561, Subsequent Discovery of Facts Existing at the Date 
of the Auditor's Report (AICPA, Professional Standards, vol. 1, AU sec. 561). Also, see SAS No. 37, Filings 
Under Federal Securities Statutes (AICPA, Professional Standards, vol. 1, AU sec. 711) as to an auditor's 
responsibility when his or her report is included in a registration statement filed under the Securities Act of 
1933. 
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e. Make such additional inquiries or perform such other procedures as considered necessary 
and appropriate to dispose of questions that arise in carrying out the foregoing procedures, 
inquiries, and discussions. 
Forming an Opinion 
65. The practitioner should consider the concept of materiality discussed in paragraphs 21 through 
23, and the impact of any modification of the auditor's report on the historical financial statements 
in forming an opinion on the examination of MD&A, including the practitioner's ability to evaluate 
the results of inquiries and other procedures. 
Reporting 
66. In order for the practitioner to issue a report on an examination of MD&A, the financial 
statements for the periods covered by the MD&A presentation and the related auditor's report(s) 
should accompany the MD&A presentation (or, with respect to a public entity, be incorporated in 
the document containing the MD&A by reference to information filed with a regulatory agency). 
67. The practitioner's report on an examination of MD&A should include— 
a. A title that includes the word independent. 
b. An identification of the MD&A presentation, including the period covered. 
c. A statement that management is responsible for the preparation of the MD&A pursuant to 
Item 303 of Regulation S-K and the related published rules and regulations of the SEC and 
a statement that the practitioner's responsibility is to express an opinion on the 
presentation based on his or her examination. 
d. A reference to the auditor's report on the related financial statements, and if the report was 
other than a standard report, the substantive reasons therefor. 
e. A statement that the examination was made in accordance with standards established by 
the AICPA and a description of the scope of an examination of MD&A. 
f. A statement that the practitioner believes that his or her examination provides a reasonable 
basis for his or her opinion. 
g. A paragraph stating that (1) the preparation of MD&A in conformity with the published 
rules and regulations of the SEC requires management to interpret the criteria, make 
determinations as to the relevancy of information to be included, and make estimates and 
assumptions that affect reported information, and (2) actual results in the future may differ 
materially from management's present assessment of information regarding the estimated 
future impact of expected transactions and events, expected sources of liquidity and capital 
resources, operating trends, commitments, and uncertainties. 
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h. If the entity is a nonpublic entity, a statement that, although the enti ty is not subject to the 
rules and regulations of the SEC, the M D & A presentation is intended to be a presentation 
in accordance w i th the published rules and regulations of the SEC. 
i. The practitioner's opinion on whether (1) the presentation includes, in all material respects, 
the required elements of I tem 303 of Regulation S-K and the related published SEC rules 
and regulations, (2) the historical financial amounts have been accurately derived, in all 
material respects, f rom the enti ty 's financial statements, and (3) the underlying informat ion 
and assumpt ions of the enti ty provide a reasonable basis for the disclosures contained 
therein. 
68. The fol lowing is an illustration of such a report on the M D & A presentation of a public enti ty: 
Independent Accoun tan t ' s Report 
[Introductory paragraph] 
We have examined XYZ Company 's Management 's Discussion and 
Ana lys is , included [ incorporated by reference] in the Company 's 
Annua l Report on Form 10-K18 for the year ended December 3 1 , 
1 9 X 5 . Management is responsible for the preparation of the 
Company's Management's Discussion and Analysis pursuant to Item 
3 0 3 of Regulation S-K and the related published rules and 
regulations of the Securities and Exchange Commiss ion. Our 
responsibility is to express an o p i n i o n on the presentation based on 
our examinat ion. We have audited, in accordance w i th generally 
accepted audit ing standards, the financial statements of XYZ 
Company as of December 3 1 , 1 9 X 5 and 19X4 , and for each of the 
years in the three-year period ended December 3 1 , 1 9 X 5 , and in our 
report dated Month XX, 19X6, w e expressed an unqualif ied opinion 
on those financial s tatements.1 9 
18 
If the practitioner is reporting on an MD&A presentation included in a document other than a Form 
10-K, such document should be appropriately described. For example, if the MD&A presentation is included 
in the entity's annual report to shareholders, this sentence might be replaced by the following: 
We have examined the accompanying XYZ Company's Management's Discussion and 
Analysis included in the Company's 19X5 Annual Report to Shareholders. 
19If prior financial statements were audited by other auditors, this sentence would be replaced by 
the following: 
We have audited, in accordance with generally accepted auditing 
standards, the financial statements of XYZ Company as of and for the year 
ended December 3 1 , 19X5, and in our report dated Month XX, 19X6, we 
expressed an unqualified opinion on those financial statements. The 
financial statements of XYZ Company as of December 3 1 , 19X4 and for 
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[Scope paragraph] 
Our examination was made in accordance w i th standards 
established by the American Institute of Certified Public Accountants 
and, accordingly, included examining, on a tes t basis, evidence 
support ing the historical amounts and disclosures in the 
presentation. An examination also includes assessing the signif icant 
assumpt ions and determinations made by management as to the 
relevancy of information. We believe that our examinat ion provides 
a reasonable basis for our opinion. 
[Explanatory paragraph]20 
The preparation of Management 's Discussion and Analysis in 
conformity wi th the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of information to 
be included, and make estimates and assumptions that af fect 
reported informat ion. Management 's Discussion and Analysis 
includes information regarding the est imated future impact of 
expected transactions and events, expected sources of l iquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially f rom management 's 
present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Opinion paragraph] 
In our opinion, the Company 's Management 's Discussion and 
Analysis includes, in all material respects, the required elements of 
Item 303 of Regulation S-K and the related published rules and 
regulations of the Securities and Exchange Commission; the 
histor ical financial amounts included therein have been accurately 
each of the years in the two-year period then ended were audited by other 
auditors, whose report dated Month XX, 19X5, expressed an unqualified 
opinion on those financial statements. 
20 
The following sentence should be added to the beginning of the explanatory paragraph if the 
entity is a nonpublic entity, as discussed in paragraph 67h: 
Although XYZ Company is not subject to the rules and regulations of the 
Securities and Exchange Commission, the accompanying Management's 
Discussion & Analysis is intended to be a presentation in accordance with 
the published rules and regulations of the Securities and Exchange 
Commission. 
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derived, in all material respects, from the Company's financial 
statements; and the underlying information and assumptions of the 
Company provide a reasonable basis for the disclosures contained 
therein. 
69. Dating. The practitioner's report on the examination of MD&A should be dated as of the 
completion of the practitioner's examination procedures. That date should not precede the date 
of the auditor's report on the latest historical financial statements covered by the MD&A. 
70. Report Modifications. The practitioner should modify the standard report in paragraph 68, if 
any of the following conditions exist: 
• The presentation excludes a material required element under Item 303 of Regulation S-K 
and the related published SEC rules and regulations (paragraph 71) 
• The historical financial amounts have not been accurately derived from the entity's financial 
statements (paragraph 71) 
• The underlying information and assumptions used by management do not provide the entity 
with a reasonable basis for the disclosure in the MD&A (paragraph 71) 
• There is a restriction on the scope of the engagement (paragraph 72) 
• The practitioner decides to refer to the report of another practitioner as the basis, in part, 
for his or her report (paragraphs 73 through 76) 
• The practitioner is engaged to examine the MD&A presentation after it has been filed with 
the SEC (or other regulatory agency) (paragraphs 98 through 100). 
7 1 . When the MD&A presentation excludes a material required element, historical financial 
amounts have not been accurately derived, or the underlying information and assumptions of the 
entity do not provide a reasonable basis for the disclosures (for example, there is a lack of 
consistency between management's method of measuring nonfinancial data between periods 
covered by the MD&A presentation), the practitioner should express a qualified or an adverse 
opinion. The basis for such opinion should be stated in the practitioner's report. An example of 
such a modification for a qualified opinion follows: 
[Additional explanatory paragraph preceding the opinion paragraph] 
Based on information furnished to us by management, we believe 
that the Company has excluded a discussion of the significant 
capital outlay required for its plans to expand into the 
telecommunications industry and the possible effects on the 
Company's financial condition, liquidity, and capital resources. 
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[Opinion paragraph] 
In our opinion, except for the omission of the matter described in the 
preceding paragraph, the Company's Management's Discussion and 
Analysis includes, in all material respects, the required elements of 
Item 303 of Regulation S-K and the related published rules and 
regulations of the Securities and Exchange Commission; the 
historical financial amounts included therein have been accurately 
derived, in all material respects, from the Company's financial 
statements; and the underlying information and assumptions of the 
Company provide a reasonable basis for the disclosures contained 
therein. 
72. If the practitioner is unable to perform the procedures he or she considers necessary in the 
circumstances, the practitioner should describe the limitation on the scope of the examination in 
an explanatory paragraph and qualify his or her opinion, or disclaim an opinion. However, 
limitations on the ability of the practitioner to perform necessary procedures could also arise 
because of the lack of adequate support for a significant representation in the MD&A. That 
circumstance may result in a conclusion that the unsupported representation constitutes a material 
misstatement of fact and, accordingly, the practitioner may qualify his or her opinion as described 
in paragraph 7 1 , or express an adverse opinion. 
73. Reference to Report of Another Practitioner. If a predecessor practitioner examined the 
MD&A for a prior period, the practitioner may decide to make reference to such report of the 
predecessor practitioner as a basis for his or her opinion on the current MD&A presentation. The 
practitioner should disclose this fact in the introductory paragraph of the report and should refer 
to the report of the other practitioner in expressing an opinion on the current MD&A presentation. 
These references indicate a division of responsibility for performance of the examination. Refer 
to paragraphs 105 through 111 for guidance concerning communicating with the predecessor 
practitioner. 
74. The following is an illustration of an examination report indicating a division of responsibility 
with the predecessor practitioner: 
Independent Accountant's Report 
[Introductory paragraphs] 
We have examined XYZ Company's Management's Discussion and 
Analysis, included [incorporated by reference] in the Company's 
Annual Report on Form 10-K for the year ended December 3 1 , 
19X5. Management is responsible for the preparation of the 
Company's Management's Discussion and Analysis pursuant to Item 
303 of Regulation S-K and the related published rules and 
regulations of the Securities and Exchange Commission. Our 
responsibility is to express an opinion on the presentation based on 
our examination. We did not examine information included in the 
35 
aforementioned Management's Discussion and Analysis for periods 
prior to January 1, 19X5, which information was examined by other 
accountants as part of their examination of XYZ Company's 
Management's Discussion and Analysis included [incorporated by 
reference] in the Company's Annual Report on Form 10-K for the 
year ended December 3 1 , 19X4; the other accountants' report has 
been furnished to us and our opinion, insofar as it relates to 
information as of and for the year ended December 3 1 , 19X4 and 
prior, is based solely on the report of the other accountants. 
We have audited, in accordance with generally accepted auditing 
standards, the financial statements of XYZ Company as of and for 
the year ended December 3 1 , 19X5, and in our report dated Month 
XX, 19X6, we expressed an unqualified opinion on those financial 
statements. The financial statements of XYZ Company as of 
December 3 1 , 19X4 and for each of the two years then ended were 
audited by other auditors, whose report dated Month XX, 19X5, 
expressed an unqualified opinion on those financial statements. 
[Scope paragraph] 
Our examination of Management's Discussion and Analysis was 
made in accordance with standards established by the American 
Institute of Certified Public Accountants and, accordingly, included 
examining, on a test basis, evidence supporting the historical 
amounts and disclosures in the presentation. An examination also 
includes assessing the significant assumptions and determinations 
made by management as to the relevancy of information. We 
believe that our examination and the report of the other accountants 
provide a reasonable basis for our opinion. 
[Explanatory paragraph]21 
The preparation of Management's Discussion and Analysis in 
conformity with the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of information to 
be included, and make estimates and assumptions that affect 
reported information. Management's Discussion and Analysis 
includes information regarding the estimated future impact of 
expected transactions and events, expected sources of liquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially from management's 
21If the entity is a nonpublic entity, refer to footnote 20 to paragraph 68 for the additional sentence 
to be added to the beginning of the explanatory paragraph. 
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present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Opinion paragraph] 
In our opinion, based on our examination and the report of the other 
accountants, the Company's Management's Discussion and Analysis 
included [incorporated by reference] in the Company's Annual 
Report on Form 10-K for the year ended December 3 1 , 19X5 
includes, in all material respects, the required elements of Item 303 
of Regulation S-K and the related published rules and regulations of 
the Securities and Exchange Commission; the historical financial 
amounts included therein have been accurately derived, in all 
material respects, from the Company's financial statements; and the 
underlying information and assumptions of the Company provide a 
reasonable basis for the disclosures contained therein. 
75. The following is an illustration of an examination report indicating a division of responsibility 
with the predecessor practitioner when the MD&A has been restated for a pooling of interests and 
the practitioner reporting is serving as the principal auditor of the related financial statements: 
Independent Accountant's Report 
[Introductory paragraphs] 
We have examined XYZ Company's Management's Discussion and 
Analysis, included [incorporated by reference] in the Company's 
Annual Report on Form 10-K for the year ended December 3 1 , 
19X5. Management is responsible for the preparation of the 
Company's Management's Discussion and Analysis pursuant to Item 
303 of Regulation S-K and the related published rules and 
regulations of the Securities and Exchange Commission. Our 
responsibility is to express an opinion on the presentation based on 
our examination. The Company's Management's Discussion and 
Analysis gives retroactive effect to the merger of XYZ Company and 
ABC Corporation in 19X5, which has been accounted for as a 
pooling of interests. We did not examine ABC Corporation's 
Management's Discussion and Analysis included in ABC 
Corporation's Annual Report on Form 10-K for the years ended 
December 31 , 19X4. Such Management's Discussion and Analysis 
was examined by other accountants, whose report has been 
furnished to us, and our opinion, insofar as it relates to information 
included for ABC Corporation as of and for the year ended 
December 3 1 , 19X4 and prior, is based solely on the report of the 
other accountants. 
37 
We have audited, in accordance with generally accepted auditing 
standards, the financial statements of XYZ Company as of 
December 3 1 , 19X5 and 19X4, and for each of the years in the 
three-year period ended December 3 1 , 19X5, and in our report 
dated Month XX, 19X6, we expressed an unqualified opinion on 
those financial statements based on our audit and the report of other 
auditors. The financial statements of ABC Corporation as of 
December 3 1 , 19X4 and for each of the two years then ended were 
audited by other auditors, whose report dated Month XX, 19X5, 
expressed an unqualified opinion on those financial statements. 
[Scope paragraph] 
Our examination of Management's Discussion and Analysis was 
made in accordance with standards established by the American 
Institute of Certified Public Accountants and, accordingly, included 
examining, on a test basis, evidence supporting the historical 
amounts and disclosures in the presentation. An examination also 
includes assessing the significant assumptions and determinations 
made by management as to the relevancy of information. We 
believe that our examination and the report of the other accountants 
provide a reasonable basis for our opinion. 
[Explanatory paragraph] 22 
The preparation of Management's Discussion and Analysis in 
conformity with the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of information to 
be included, and make estimates and assumptions that affect 
reported information. Management's Discussion and Analysis 
includes information regarding the estimated future impact of 
expected transactions and events, expected sources of liquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially from management's 
present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Opinion paragraph] 
In our opinion, based on our examination and the report of the other 
accountants, the Company's Management's Discussion and Analysis 
22If the entity is a nonpublic entity, refer to footnote 20 to paragraph 68 for the additional sentence 
to be added to the beginning of the explanatory paragraph. 
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included [incorporated by reference] in the Company's Annual 
Report on Form 10-K for the year ended December 3 1 , 19X5 
includes, in all material respects, the required elements of Item 303 
of Regulation S-K and the related published rules and regulations of 
the Securities and Exchange Commission; the historical financial 
amounts included therein have been accurately derived, in all 
material respects, from the Company's financial statements; and the 
underlying information and assumptions of the Company provide a 
reasonable basis for the disclosures contained therein. 
76. When the practitioner is unable to serve as the principal auditor,23 the practitioner may report 
on the combination of the MD&A. The following is an illustration of appropriate reporting on such 
combination that can be presented in an additional paragraph of the practitioner's report following 
the opinion paragraph covering the periods he or she has examined: 
We have previously examined and reported on the Management's Discussion and Analysis of XYZ 
Company, included [incorporated by reference] in the Company's Annual Report on Form 10-K for 
the year ended December 3 1 , 19X4, prior to the restatement of such information for the 19X5 
pooling of interests. Separate management's discussion and analyses of the other companies 
included for periods prior to January 1, 19X5 were examined and reported on separately by other 
accountants. We also examined the combination of the accompanying Management's Discussion 
and Analysis with respect to periods prior to January 1, 19X5, after restatement for the 19X5 
pooling of interests; in our opinion, such management's discussions and analyses have been 
properly combined. 
77. Emphasis of a Matter. In some circumstances, the practitioner may wish to emphasize a 
matter regarding the MD&A presentation. For example, he or she may wish to emphasize that the 
entity has included information beyond the required elements under Item 303 of Regulation S-K 
and the related published SEC rules and regulations. Such explanatory comments should be 
presented in a separate paragraph of the practitioner's report. 
Communications With the Audit Committee 
78. If the practitioner concludes that the MD&A presentation contains material inconsistencies 
with other information included in the document containing the MD&A presentation or with the 
historical financial statements,24 material omissions, or material misstatements of fact, and 
23Paragraphs 16 and 17 of SAS No. 1, AU section 543, "Part of Audit Performed by Other 
Independent Auditors" (AICPA, Professional Standards, vol. 1, AU sec. 543) provides guidance concerning 
reporting on restated financial statements of prior years following a pooling of interests. 
24
 See SAS No. 8, Other Information in Documents Containing Audited Financial Statements (AICPA, 
Professional Standards, vol. 1, AU sec. 550), for guidance on the impact of material inconsistencies or 
material misstatements of fact on the auditor's report on the related historical financial statements. As 
stated in paragraph 3 of SAS No. 8, such statement is not applicable when the financial statements and 
auditor's report appear in a registration statement filed under the Securities Act of 1933 or to other 
information on which the auditor is engaged to express an opinion. 
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management refuses to take corrective action, the practitioner should inform the audit committee, 
or others with equivalent authority and responsibility. If the MD&A is not revised, the practitioner 
should evaluate (a) whether to resign from the engagement related to the MD&A, and (b) whether 
to remain as the entity's auditor or stand for reelection to audit the entity's financial statements. 
The practitioner may wish to consult with his or her attorney when making these evaluations. 
REVIEW ENGAGEMENT 
79. The objective of a review engagement, including a review of MD&A for an interim period, is 
described in paragraph 8. MD&A for an interim period may be a free-standing presentation or it 
may be combined with the MD&A presentation for the most recent fiscal year. Procedures for 
conducting a review of MD&A generally are limited to inquiries and analytical procedures, rather 
than also including search and verification procedures, concerning factors that have a material 
effect on financial condition, including liquidity and capital resources, results of operations, and 
cash flows. In a review engagement, the practitioner should — 
a. Obtain an understanding of the published SEC rules and regulations for MD&A and 
management's method of preparing MD&A (paragraphs 18 and 19). 
b. Plan the engagement (paragraph 80). 
c. Consider relevant portions of the entity's internal control applicable to the preparation of 
the MD&A (paragraph 81). 
d. Apply analytical procedures to the financial statements and related MD&A and make 
inquiries of management and others (paragraphs 82 through 84). 
e. Consider events subsequent to the balance-sheet date. The practitioner's consideration of 
events subsequent to the balance-sheet date in a review of MD&A is similar to the 
practitioner's consideration in an examination (refer to paragraphs 63 and 64). 
f. Obtain written representations from management concerning its responsibility for the 
MD&A, completeness of minutes, events subsequent to the balance-sheet date, and other 
matters about which the practitioner believes written representations are appropriate 
(paragraph 114). 
g. Form a conclusion whether any information came to the practitioner's attention that causes 
him or her to believe that (a) the MD&A does not include the required elements of Item 303 
of Regulation S-K and the related published SEC rules and regulations, (b) the historical 
financial amounts included therein have not been accurately derived from the entity's 
financial statements, or (c) the underlying information and assumptions of the entity do not 
provide a reasonable basis for the disclosures contained therein. 
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Planning the Engagement 
80. Planning an engagement to review MD&A involves developing an overall strategy for the 
analytical procedures and inquiries to be performed. When developing an overall strategy for the 
review engagement, the practitioner should consider factors such as the following: 
• Matters affecting the industry in which the entity operates, such as financial reporting 
practices, economic conditions, laws and regulations, and technological changes 
• Matters relating to the entity's business, including its organization, operating 
characteristics, capital structure, and distribution methods 
• The types of relevant information that management reports to external analysts (for 
example, press releases, or presentations to lenders and rating agencies concerning past 
and future performance) 
• The extent of management's knowledge of and experience with the published SEC rules 
and regulations 
• If the entity is a nonpublic entity, the intended use of the MD&A presentation 
• Matters identified during the audit or review of the historical financial statements relating 
to MD&A reporting, including knowledge of the entity's internal control applicable to the 
preparation of MD&A and the extent of recent changes, if any 
• Matters identified during prior engagements to examine or review MD&A 
• The nature of complex or subjective matters potentially material to the MD&A that may 
require special skill or knowledge 
• The presence of an internal audit function and the extent to which internal auditors are 
involved in directly testing the MD&A presentation or underlying records 
Consideration of Internal Control Applicable to the Preparation of MD&A 
8 1 . To perform a review of MD&A, the practitioner needs to have sufficient knowledge of the 
entity's internal control applicable to the preparation of MD&A to — 
• Identify types of potential misstatements in the MD&A, including types of material 
omissions, and consider the likelihood of their occurrence. 
• Select the inquiries and analytical procedures that will provide a basis for reporting whether 
any information causes the practitioner to believe that— 
a. The MD&A does not include the required elements of Item 303 of Regulation S-K 
and the related published rules and regulations of the SEC, or the historical financial 
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amounts included therein have not been accurately derived from the entity's 
financial statements. 
b. The underlying information and assumptions of the entity do not provide a 
reasonable basis for the disclosures contained therein. 
Application of Analytical Procedures and Inquiries 
82. The practitioner ordinarily would not obtain corroborating evidential matter of management's 
responses to the practitioner's inquiries in performing a review of MD&A. The practitioner should, 
however, consider the consistency of management's responses in light of the results of other 
inquiries and the application of analytical procedures. The practitioner ordinarily should apply the 
following analytical procedures: 
a. Read the MD&A and compare the content for consistency with the audited financial 
statements (or reviewed interim financial information if the MD&A includes interim 
information) or related accounting records and analyses; recompute increases, decreases, 
and percentages disclosed. 
b. Compare nonfinancial amounts to the audited (or reviewed) financial statements, if 
applicable, or to other records (refer to paragraph 83). 
c. Consider whether explanations are consistent with information obtained during the audit 
or the review of interim financial information; make further inquiries of officers and other 
executives having responsibility for operational areas as necessary. 
d. Obtain available prospective financial information (for example, budgets; sales forecasts; 
forecasts of labor, overhead and materials costs; capital expenditure requests; and financial 
forecasts and projections) and compare such information to forward-looking MD&A 
disclosures. Consider whether the underlying information and assumptions of the entity 
do not provide a reasonable basis for the disclosures of trends, demands, commitments, 
events, or uncertainties. 
e. Make inquiries of officers and other executives having responsibility for operational areas 
(such as sales, marketing, and production) and financial and accounting matters, as to any 
plans and expectations for the future that could affect the entity's liquidity and capital 
resources. 
f. Compare the information in the MD&A with the published SEC rules and regulations. 
g. Read the minutes of meetings to date of the board of directors and other significant 
committees to identify actions that may affect MD&A; consider whether such matters are 
appropriately addressed in the MD&A. 
h. Inquire of officers as to the entity's prior experience with the SEC and the extent of 
comments received upon review of documents by the SEC; read correspondence between 
the entity and the SEC with respect to such review, if any. 
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i. Obtain public communicat ions (for example, press releases and quarterly reports) dealing 
w i t h histor ical and future results; consider whether the M D & A is consistent w i t h such 
communicat ions. 
83. If nonfinancial data is included in the M D & A , the practit ioner should inquire as to the nature 
of the records f rom which such information was derived and observe the existence of such 
records, but need not perform other tests of such records beyond analytical procedures and 
inquiries of individuals responsible for maintaining them. The practit ioner should consider whether 
such nonfinancial data is relevant to users of the M D & A and whether it is clearly defined in the 
MD&A. The practitioner should make inquiries regarding whether the definit ion of the nonfinancial 
data was consistent ly applied during the periods reported. 
84 . However, if the practit ioner becomes aware that the presentation may be incomplete, or 
contain inaccuracies, or is otherwise unsat isfactory, the practit ioner should perform the additional 
procedures he or she deems necessary to achieve the l imited assurance contemplated by a review 
engagement. 
Reporting 
85. In order for the practit ioner to issue a report on a review of M D & A for an annual period, the 
financial s tatements for the periods covered by the M D & A presentation and the related auditor 's 
report(s) should accompany the M D & A presentation (or, w i t h respect to a public ent i ty, be 
incorporated in the document containing the M D & A by reference to informat ion filed w i th a 
regulatory agency). 
8 6 . If the M D & A presentation relates to an interim period and the ent i ty is a public ent i ty, the 
f inancial statements for the interim periods covered by the M D & A presentation and the related 
accountant's review report(s) should accompany the MD&A presentation, or be incorporated in the 
document containing the M D & A by reference to information filed w i th a regulatory agency. 
General ly, the requirement for inclusion of the annual f inancial statements and related 
management 's discussion and analysis is satisfied by a public ent i ty tha t has met its report ing 
responsibility for filing its annual financial statements and M D & A in its annual report on Form 10-K. 
87. If the MD&A presentation relates to an interim period and the enti ty is a nonpublic ent i ty, the 
fol lowing documents should accompany the interim M D & A presentation in order for the practit ioner 
to issue a review report: 
a. The M D & A presentation for the most recent f iscal year and related accountant 's 
examination or review report(s) 
b. The f inancial s tatements for the periods covered by the respective M D & A presentations 
(most recent fiscal year and interim periods and the related auditor 's report(s) and 
accountant 's review report(s)). 
8 8 . The pract i t ioner 's report on a review of M D & A should include— 
a. A t i t le that includes the word independent. 
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b. An identification of the MD&A presentation, including the period covered. 
c. A statement that management is responsible for the preparation of the MD&A pursuant to 
Item 303 of Regulation S-K and the related published rules and regulations of the SEC. 
d. A reference to the auditor's report on the related financial statements, and, if the report 
was other than a standard report, the substantive reasons therefor. 
e. A statement that the review was conducted in accordance with standards established by 
the AICPA. 
f. A description of the procedures for a review of MD&A. 
g. A statement that a review of MD&A is substantially less in scope than an examination, the 
objective of which is an expression of opinion regarding the MD&A presentation, and 
accordingly, no such opinion is expressed. 
h. A paragraph stating that (1) the preparation of MD&A in conformity with the published 
rules and regulations of the SEC requires management to interpret the criteria, make 
determinations as to the relevancy of information to be included, and make estimates and 
assumptions that affect reported information, and (2) actual results in the future may differ 
materially from management's present assessment of information regarding the estimated 
future impact of expected transactions and events, expected sources of liquidity and capital 
resources, operating trends, commitments, and uncertainties. 
i. If the entity is a nonpublic entity, a statement that although the entity is not subject to the 
rules and regulations of the SEC, the MD&A presentation is intended to be a presentation 
in accordance with the published rules and regulations of the SEC. 
j . A statement about whether any information came to the practitioner's attention that 
caused him or her to believe that (1) the MD&A presentation does not include the required 
elements of Item 303 of Regulation S-K and the related published rules and regulations of 
the SEC, (2) the historical financial amounts included therein have not been accurately 
derived from the entity's financial statements, or (3) the underlying information and 
assumptions of the entity do not provide a reasonable basis for the disclosures contained 
therein. 
89. The following is an illustration of a review report on an annual MD&A presentation of a public 
entity: 
44 
Independent Accountan t ' s Report 
[Introductory paragraph] 
We have reviewed XYZ Company 's Management 's Discussion and 
Ana lys is , included [ incorporated by reference] in the Company 's 
Annua l Report on Form 10-K25 for the year ended December 3 1 , 
1 9 X 5 . Management is responsible for the preparation of the 
Company's Management's Discussion and Analysis pursuant to I tem 
3 0 3 of Regulation S-K and the related published rules and 
regulations of the Securities and Exchange Commission. We have 
audited, in accordance w i th generally accepted audit ing standards, 
the financial statements of XYZ Company as of December 3 1 , 19X5 
and 19X4, and for each of the years in the three-year period ended 
December 3 1 , 19X5, and in our report dated Month XX, 19X6, w e 
expressed an unqualif ied opinion on those financial s tatements. 
[Scope paragraph] 
We conducted our review in accordance w i t h standards established 
by the American Institute of Certified Public Accountants . A review 
of management 's discussion and analysis consists principally of 
apply ing analytical procedures and making inquiries of persons 
responsible for f inancial, account ing, and operational matters. It is 
substantial ly less in scope than an examinat ion, the objective of 
w h i c h is the expression of an opinion on the presentat ion. 
Accordingly, we do not express such an opinion. 
[Explanatory paragraph]26 
The preparation of Management 's Discussion and Analysis in 
conformity w i t h the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of informat ion to 
be included, and make est imates and assumptions that af fect 
reported informat ion. Management 's Discussion and Analysis 
includes informat ion regarding the est imated future impact of 
expected transactions and events, expected sources of l iquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially f rom management 's 
25If the practitioner is reporting on MD&A included in a document other than a Form 10-K, such 
document should be appropriately described (refer to footnote 18). 
26If the entity is a nonpublic entity, refer to footnote 20 to paragraph 68 for the additional sentence 
to be added to the beginning of the explanatory paragraph as discussed in paragraph 88i. 
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present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Concluding paragraph] 
Based on our review, nothing came to our attention that caused us 
to believe that the presentation does not include the required 
elements of Item 303 of Regulation S-K and the related published 
rules and regulations of the Securities and Exchange Commission, 
that the historical financial amounts included therein have not been 
accurately derived from the Company's financial statements, or that 
the underlying information and assumptions of the Company do not 
provide a reasonable basis for the disclosures contained therein. 
90. The following is an illustration of a review report on an MD&A presentation of a public entity 
for an interim period: 
Independent Accountant's Report 
[Introductory paragraph] 
We have reviewed XYZ Company's Management's Discussion and 
Analysis included in the Company's Report on Form 10-Q for the 
quarterly period ended June 30, 19X6. Management is responsible 
for the preparation of the Company's Management's Discussion and 
Analysis pursuant to Item 303 of Regulation S-K and the related 
published rules and regulations of the Securities and Exchange 
Commission. We have reviewed, in accordance with standards 
established by the American Institute of Certified Public 
Accountants, the interim financial information of XYZ Company as 
of June 30, 19X6 and 19X5, and for the three-month and six-month 
periods then ended, and have issued our report thereon dated July 
XX, 19X6. 
[Scope paragraph] 
We conducted our review in accordance with standards established 
by the American Institute of Certified Public Accountants. A review 
of management's discussion and analysis consists principally of 
applying analytical procedures and making inquiries of persons 
responsible for financial, accounting, and operational matters. It is 
substantially less in scope than an examination, the objective of 
which is the expression of an opinion on the presentation. 
Accordingly, we do not express such an opinion. 
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[Explanatory paragraph]27 
The preparation of Management 's Discussion and Analysis in 
conformity w i th the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of informat ion to 
be included, and make estimates and assumptions that af fect 
reported informat ion. Management 's Discussion and Analysis 
includes informat ion regarding the est imated future impact of 
expected transactions and events, expected sources of l iquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially f rom management 's 
present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Concluding paragraph] 
Based on our review, nothing came to our at tent ion that caused us 
to believe tha t the presentation does not include the required 
e lements of Item 303 of Regulation S-K and the related published 
rules and regulations of the Securities and Exchange Commiss ion, 
that the historical f inancial amounts included therein have not been 
accurately derived from the Company's financial s tatements, or tha t 
the underlying information and assumptions of the Company do not 
provide a reasonable basis for the disclosures contained therein. 
9 1 . Dating. The pract i t ioner's report on the review of M D & A should be dated as of the 
completion of the practit ioner's review procedures. That date should not precede the date of the 
accountant 's report on the latest historical financial s tatements covered by the M D & A . 
92 . Report Modifications. The practitioner should modify the standard review report in paragraphs 
89 and 90 if any of the fo l lowing condit ions exist: 
• The practitioner decides to refer t o the report of another practit ioner as the basis, in part, 
for his or her report (paragraphs 94 and 95) 
• The presentation excludes a material required element under Item 3 0 3 of Regulation S-K 
and the related published SEC rules and regulations (paragraph 96) 
• The historical financial amounts have not been accurately derived f rom the ent i ty 's financial 
s tatements 
27 
If the entity is a nonpublic entity, refer to footnote 20 to paragraph 68 for the additional sentence 
to be added to the beginning of the explanatory paragraph, as discussed in paragraph 88i. 
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• The underlying information and assumptions used by management do not provide the entity 
with a reasonable basis for the disclosures in the MD&A 
• The practitioner is engaged to review the MD&A presentation after it has been filed with 
the SEC (or other regulatory agency) (paragraphs 98 through 100). 
93. When the practitioner is unable to perform the inquiry and analytical procedures he or she 
considers necessary to achieve the limited assurance provided by a review, or the client does not 
provide the practitioner with a representation letter, the review will be incomplete. A review that 
is incomplete is not an adequate basis for issuing a review report. When the practitioner is unable 
to complete a review because of a scope limitation, the practitioner should consider the 
implications of that limitation with respect to possible misstatements of the MD&A presentation. 
In those circumstances, the practitioner should also refer to paragraph 78 for guidance. 
94. If a predecessor practitioner reviewed or examined the MD&A for a prior period, the 
practitioner may decide to make reference to such report of the predecessor practitioner in 
reporting on the current MD&A presentation. Such references indicate a division of responsibility 
for performance of the review. 
95. The following is an illustration of a report that makes reference to the review report of the 
predecessor practitioner for an interim period: 
Independent Accountant's Report 
[Introductory paragraphs] 
We have reviewed XYZ Company's Management's Discussion and 
Analysis, included in the Company's Report on Form 10-Q for the 
quarterly period ended June 30, 19X6. Management is responsible 
for the preparation of the Company's Management's Discussion and 
Analysis pursuant to Item 303 of Regulation S-K and the related 
published rules and regulations of the Securities and Exchange 
Commission. We did not review information included in the 
aforementioned Management's Discussion and Analysis for periods 
prior to January 1, 19X6, which information was reviewed by other 
accountants as part of their review of XYZ Company's 
Management's Discussion and Analysis included in the Company's 
Report on Form 10-Q for the quarterly period ended June 30, 19X5. 
The other accountants' report has been furnished to us, and our 
report, insofar as it relates to information included for the three-
month and six-month periods ended June 30, 19X5 and prior is 
based solely on the report of the other accountants. 
We have reviewed, in accordance with standards established by the 
American Institute of Certified Public Accountants, the interim 
financial information of XYZ Company as of June 30, 19X6, and for 
the three-month and six-month periods then ended, and have issued 
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our report thereon dated July XX, 19X6. The interim financial 
information of XYZ Company as of June 30, 19X5 and for the three-
month and six-month periods then ended were reviewed by other 
accountants, who have issued their report thereon dated Month XX, 
19X5. 
[Scope paragraph] 
We conducted our review in accordance with standards established 
by the American Institute of Certified Public Accountants. A review 
of management's discussion and analysis consists principally of 
applying analytical procedures and making inquiries of persons 
responsible for financial, accounting, and operational matters. It is 
substantially less in scope than an examination, the objective of 
which is the expression of an opinion on the presentation. 
Accordingly, we do not express such an opinion. 
[Explanatory paragraph]28 
The preparation of Management's Discussion and Analysis in 
conformity with the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of information to 
be included, and make estimates and assumptions that affect 
reported information. Management's Discussion and Analysis 
includes information regarding the estimated future impact of 
expected transactions and events, expected sources of liquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially from management's 
present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Concluding paragraph] 
Based on our review and the report of other accountants, nothing 
came to our attention that caused us to believe that the Company's 
Management's Discussion and Analysis included in the Company's 
Report on Form 10-Q for the quarterly period ended June 30, 19X6 
does not include the required elements of Item 303 of Regulation S-
K and the related published rules and regulations of the Securities 
and Exchange Commission, that the historical financial amounts 
included therein have not been accurately derived from the 
Company's financial statements, or that the underlying information 
28 
If the entity is a nonpublic entity, refer to footnote 20 to paragraph 68 for the additional sentence 
to be added to the beginning of the explanatory paragraph, as discussed in paragraph 88i. 
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and assumptions of the Company do not provide a reasonable basis 
for the disclosures contained therein. 
96. If the practitioner becomes aware that the MD&A is materially misstated, the practitioner 
should modify the review report to describe the nature of the misstatement. An example of such 
a modification of the accountant's report follows: 
[Additional explanatory paragraph preceding the opinion paragraph] 
Based on information furnished us by management, we believe that 
the Company has excluded a discussion of the significant capital 
outlay required for its plans to expand into the telecommunications 
industry and the possible effects on the Company's financial 
condition, liquidity, and capital resources. 
[Concluding paragraph] 
Based on our review, with the exception of the matter described in 
the preceding paragraph, nothing came to our attention that caused 
us to believe that the presentation does not include the required 
elements of Item 303 of Regulation S-K and the related published 
rules and regulations of the Securities and Exchange Commission, 
that the historical financial amounts included therein have not been 
accurately derived from the Company's financial statements, or that 
the underlying information and assumptions of the Company do not 
provide a reasonable basis for the disclosures contained therein. 
COMBINED EXAMINATION AND REVIEW REPORT ON MD&A 
97. A practitioner may be engaged both to examine MD&A as of the most recent fiscal year end 
and to review MD&A for a subsequent interim period. When the examination and review are 
completed at the same time, a combined report may be issued. An example of a combined report 
on an examination of an annual MD&A presentation and the review of MD&A for an interim period 
follows: 
Independent Accountant's Report 
[Introductory paragraph] 
We have examined XYZ Company's Management's Discussion and 
Analysis for the three-year period ended December 3 1 , 19X5, 
included [incorporated by reference] in the Company's [insert 
description of registration statement or document]. Management is 
responsible for the preparation of the Company's Management's 
Discussion and Analysis pursuant to Item 303 of Regulation S-K and 
the related published rules and regulations of the Securities and 
Exchange Commission. Our responsibility is to express an opinion 
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on the presentation based on our examination. We have audited, in 
accordance with generally accepted auditing standards, the financial 
statements of XYZ Company as of December 3 1 , 19X5 and 19X4, 
and for each of the years in the three-year period ended December 
31 , 19X5, and in our report dated Month XX, 19X6, we expressed 
an unqualified opinion on those financial statements. 
[Scope paragraph] 
Our examination was made in accordance with standards 
established by the American Institute of Certified Public Accountants 
and, accordingly, included examining, on a test basis, evidence 
supporting the historical amounts and disclosures in the 
presentation. An examination also includes assessing the significant 
assumptions and determinations made by management as to the 
relevancy of information. We believe that our examination provides 
a reasonable basis for our opinion. 
[Explanatory paragraph]29 
The preparation of Management's Discussion and Analysis in 
conformity with the published rules and regulations of the Securities 
and Exchange Commission requires management to interpret the 
criteria, make determinations as to the relevancy of information to 
be included, and make estimates and assumptions that affect 
reported information. Management's Discussion and Analysis 
includes information regarding the estimated future impact of 
expected transactions and events, expected sources of liquidity and 
capital resources, operating trends, commitments, and uncertainties. 
Actual results in the future may differ materially from management's 
present assessment of this information because events and 
circumstances frequently do not occur as expected. 
[Opinion paragraph] 
In our opinion, the Company's Management's Discussion and 
Analysis for the three-year period ended December 3 1 , 19X5 
includes, in all material respects, the required elements of Item 303 
of Regulation S-K and the related published rules and regulations of 
the Securities and Exchange Commission; the historical financial 
amounts included therein have been accurately derived, in all 
material respects, from the Company's financial statements; and the 
29 
If the entity is a nonpublic entity, refer to footnote 20 to paragraph 68 for the additional sentence 
to be added to the beginning of the explanatory paragraph, as discussed in paragraph 67h. 
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underlying information and assumptions of the Company provide a 
reasonable basis for the disclosures contained therein. 
[Paragraphs on Interims] 
We have also reviewed the information included in the 
accompanying XYZ Company's Management's Discussion and 
Analysis for the six-month period ended June 30, 19X6 included 
[incorporated by reference] in the Company's [insert description of 
registration or document]. We have reviewed, in accordance with 
standards established by the American Institute of Certified Public 
Accountants, the interim financial information of XYZ Company as 
of June 30, 19X6 and 19X5, and for the six-month periods then 
ended, and have issued our report thereon dated July XX, 19X6. 
We conducted our review in accordance with standards established 
by the American Institute of Certified Public Accountants. A review 
of management's discussion and analysis consists principally of 
applying analytical procedures and making inquiries of persons 
responsible for financial, accounting, and operational matters. It is 
substantially less in scope than an examination, the objective of 
which is the expression of an opinion on the presentation. 
Accordingly, we do not express such an opinion. 
Based on our review, nothing came to our attention that caused us 
to believe that the Company's Management's Discussion and 
Analysis for the six-month period ended June 30, 19X6 does not 
include the required elements of Item 303 of Regulation S-K and the 
related published rules and regulations of the Securities and 
Exchange Commission, that the historical financial amounts included 
therein have not been properly derived from the Company's 
unaudited interim financial statements, or that the underlying 
information and assumptions of the Company do not provide a 
reasonable basis for the disclosures contained therein. 
WHEN PRACTITIONER IS ENGAGED SUBSEQUENT TO THE FILING OF MD&A 
98. Management's responsibility for updating an MD&A presentation for events occurring 
subsequent to the issuance of MD&A depends on whether the entity is a public or nonpublic entity. 
A public entity is required to report significant subsequent events in a Form 8-K or Form 10-Q; 
therefore, a public company would ordinarily not modify its MD&A presentation once it is filed with 
the SEC (or other regulatory agency). 
99. Therefore, when the practitioner is engaged to examine (or review) an MD&A presentation 
of a public entity that has already been filed with the SEC (or other regulatory agency), the 
practitioner should consider whether material subsequent events are appropriately disclosed in 
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Forms 8-K or 10-Q. If subsequent events of a public entity are appropriately disclosed in a Form 
8-K or 10-Q, the practitioner should add the following paragraph to his or her examination or 
review report following the opinion or concluding paragraph, respectively: 
The accompanying Management's Discussion and Analysis does not consider events that 
have occurred subsequent to Month XX, 19X6, the date as of which it was filed with the 
Securities and Exchange Commission. 
If such events are not appropriately disclosed, as discussed in paragraph 78, the practitioner 
should evaluate (a) whether to resign from the engagement related to the MD&A and (b) whether 
to remain as the entity's auditor or stand for reelection to audit the entity's financial statements. 
If the practitioner determines that it is appropriate to issue a report (for example, because the filing 
of the Form 10-Q that will disclose such events has not yet occurred), the practitioner should 
express a qualified or adverse opinion (or appropriately modify the review report) on the MD&A 
presentation. 
100. Because a nonpublic entity is not subject to the filing requirements of the SEC, an MD&A 
presentation of a nonpublic entity should be updated for material subsequent events through the 
date of the practitioner's report. 
WHEN A PREDECESSOR AUDITOR HAS AUDITED PRIOR YEAR FINANCIAL STATEMENTS 
101. When a predecessor auditor has audited the financial statements for a prior period covered 
by the MD&A but has not examined the MD&A for the respective period, the need by the 
practitioner reporting on the MD&A for an understanding of the business and the entity's 
accounting and financial reporting practices for such prior period, as discussed in paragraph 7, is 
not diminished and the practitioner should apply the appropriate procedures. In applying the 
appropriate procedures, the practitioner may consider reviewing the predecessor auditor's working 
papers with respect to audits of such prior periods. 
102. If the predecessor auditor is engaged to perform procedures with respect to the MD&A for 
prior periods or has examined the MD&A in prior periods, the practitioner should consider the 
guidance in "Part of Audit Performed by Other Independent Auditors" (AICPA, Professional 
Standards, vol. 1, AU sec. 543) of SAS No. 1, Codification of Auditing Standards and Procedures, 
and paragraphs 105 through 112 of this Statement. 
103. When the predecessor auditor is not engaged to perform procedures with respect to the prior 
periods, information that may be obtained from the audit working papers of the predecessor auditor 
will not provide a sufficient basis in itself for the practitioner to express an opinion with respect 
to the MD&A disclosures for such prior periods. If the practitioner has audited the current year, 
the results of such audit may be considered in planning and performing the examination of MD&A 
and may provide evidential matter that is useful in performing the examination, including with 
respect to matters disclosed for prior periods. For example, an increase in salaries expense may 
be the result of an acquisition in the last half of the prior year. Auditing procedures applied to 
payroll expense in the current year that validate the increase as a result of the acquisition may 
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provide evidential matter with respect to the increase in salaries expense in the prior year 
attributed to the acquisition. 
104. The practitioner will need to perform the following procedures, in addition to those described 
in paragraphs 47 through 64: 
a. Make inquiries of the predecessor auditor and management as to audit adjustments 
proposed by the predecessor auditor that were not recorded in the financial statements 
b. Make inquiries of management as to whether there were any changes in the procedures 
for preparing MD&A in the prior periods 
Communications Between Predecessor and Successor Auditors 
105. When the practitioner is appointed as the successor auditor, he or she follows the guidance 
in SAS No. 7, Communications Between Predecessor and Successor Auditors (AICPA, Professional 
Standards, vol. 1, AU sec. 315), in considering whether or not to accept the engagement. If at 
the time of the appointment as auditor, the practitioner is also being engaged to examine or review 
MD&A, the practitioner should also make specific inquiries of the predecessor auditor regarding 
the MD&A. 
106. The practitioner's examination may be facilitated by (a) making specific inquiries of the 
predecessor regarding matters that the successor believes may affect the conduct of the 
examination (or review), such as areas that required an inordinate amount of time or problems that 
arose from the condition of the records, if the predecessor previously examined or reviewed 
MD&A, and (b) reviewing the predecessor's working papers for the predecessor's examination or 
review engagement. 
107. If subsequent to his or her engagement to audit the financial statements the practitioner is 
requested to examine MD&A, the practitioner should request the client to authorize the 
predecessor auditor to allow a review of the predecessor's audit working papers related to the 
financial statement periods included in the MD&A. Although the practitioner may previously have 
had access to the predecessor auditor's working papers in connection with the successor's audit 
of the financial statements, ordinarily the predecessor auditor should permit the practitioner to 
review those audit working papers relating to matters disclosed, or that would likely be disclosed, 
in the MD&A. 
Referring to a Predecessor Practitioner 
108. When the practitioner intends to make reference to the examination (or review) of the 
predecessor, the successor should ascertain through communication with the predecessor that the 
predecessor is aware that the predecessor's report on MD&A will be referred to in the successor's 
report and should obtain an affirmative written acknowledgment from the predecessor to such 
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reference. If the predecessor does not agree to the reference to the predecessor's report, the 
successor may be engaged to examine or review the MD&A relating to prior periods.30 
109. If the successor intends to make reference to the examination of the predecessor, the 
successor should provide a draft of the MD&A presentation and a letter of representations to the 
predecessor in conjunction with obtaining the predecessor's affirmative written acknowledgment. 
The letter of representations should state whether the successor's examination (or review) revealed 
any matters that, in the successor's opinion, might have a material effect on, or require disclosure 
in, the MD&A reported on by the predecessor. Paragraph 112 discusses the predecessor's 
responsibilities. 
110. When the practitioner makes reference to the examination (or review) of the predecessor, 
the practitioner's report should indicate clearly, in both the introductory, scope and opinion 
paragraphs (or the introductory and concluding paragraphs of a review report), the division of 
responsibility as between that portion of the MD&A covered by the practitioner's examination (or 
review) and that covered by the examination (or review) of the predecessor. Paragraphs 74 and 
95 illustrate the manner in which the division of responsibility is indicated for an examination and 
a review, respectively. The predecessor may be named but only with the predecessor's express 
permission and provided the predecessor's report is presented together with that of the 
practitioner. 
111. Reference in the report of the practitioner to the fact that part of the examination was made 
by another practitioner is not to be construed as a qualification of opinion, but rather as an 
indication of the divided responsibility between the practitioners who conducted examinations of 
the components of MD&A for different periods. 
Predecessor Practitioner's Acknowledgment Provided or Report Reissued 
112. Before providing a written acknowledgment to the successor or reissuing a report previously 
issued on the MD&A of a prior period, a predecessor practitioner should consider whether his or 
her previous report on the MD&A for the related period is still appropriate. Either the current form 
or manner of presentation of the MD&A of the prior period or one or more subsequent events (for 
example, discontinued operations) might make a predecessor's previous report inappropriate. 
Consequently, a predecessor should (a) read the financial statements and related MD&A of the 
current period, (b) compare the prior period financial statements and related MD&A that the 
predecessor reported on with the financial statements and related MD&A to be presented for 
comparative purposes, and (c) obtain a letter of representations from the successor. The 
predecessor should not refer in the reissued report to the report or work of the successor. 
30
 The guidance in Auditing Interpretation No. 3 of SAS No. 7 (AICPA, Professional Standards, vol. 
1, AU sec. 9315.08-18) may be helpful when examining MD&A that had previously been examined by a 
predecessor practitioner. 
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WHEN ANOTHER AUDITOR AUDITS A SIGNIFICANT PART OF THE FINANCIAL STATEMENTS 
113. When another auditor or auditors audit a significant part of the financial statements, the 
practitioner31 may request that such other auditor or auditors perform procedures with respect to 
the MD&A or the practitioner may perform the procedures directly with respect to such 
component(s).32 Unless the other auditor issues an examination or review report on a separate 
MD&A presentation of such component(s), the principal practitioner should not make reference to 
the work of the other practitioner in his or her report on MD&A. Accordingly, if the practitioner 
has requested such other auditor to perform procedures, the principal practitioner should perform 
those procedures that he or she considers necessary to take responsibility for the work of the other 
auditor. Such procedures may include one or more of the following: 
a. Visiting the other auditor and discussing the procedures followed and the results thereof 
b. Reviewing the working papers of the other auditor with respect to the component 
c. Participating in discussions with the component's management regarding matters that may 
affect the preparation of MD&A 
d. Making supplemental tests with respect to such component 
The determination of the extent of the procedures to be applied by the principal practitioner rests 
with the principal practitioner alone in the exercise of his or her professional judgment and in no 
way constitutes a reflection on the adequacy of the other auditor's work. Because the principal 
practitioner in this case assumes responsibility for his or her opinion on the MD&A presentation 
without making reference to the procedures performed by the other auditor, the practitioner's 
judgment must govern as to the extent of procedures to be undertaken. 
OBTAINING WRITTEN REPRESENTATIONS 
114. In an examination or a review engagement, the practitioner should obtain management's 
written representations,33 which should ordinarily include the following matters: 
31The practitioner serving as principal auditor is presumed to have an audit base for purposes of 
examining or reviewing the consolidated MD&A presentation. 
32The practitioner should consider whether he or she has sufficient industry expertise with respect 
to a subsidiary audited by another auditor to take sole responsibility for the consolidated MD&A presentation. 
33
 Paragraph 9 of SAS No. 19, Client Representations (AICPA, Professional Standards, vol. 1, AU 
sec. 333) provides guidance on the date as of which management should sign such a representation letter 
and on which member(s) of management should sign it. 
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a. Management's acknowledgment of its responsibility for the preparation of MD&A in 
accordance with Item 303 of Regulation S-K and the related published SEC rules and 
regulations for MD&A34 
b. That the historical financial amounts included in the MD&A have been accurately derived 
from the entity's financial statements 
c. Management's belief that the underlying information and assumptions of the entity provide 
a reasonable basis for the disclosures contained in the MD&A 
d. Availability of all documentation related to compliance with SEC rules and regulations for 
MD&A 
e. If a public entity, communications from the SEC concerning noncompliance with or 
deficiencies in MD&A reporting practices 
f. Whether any events occurred subsequent to the latest balance sheet date that would 
require disclosure in the MD&A 
115. Management's refusal to furnish all appropriate written representations constitutes a 
limitation on the scope of the engagement sufficient to require a qualified opinion or disclaimer of 
opinion in an examination engagement or to require withdrawal in a review engagement. Further, 
the practitioner should consider the effects of management's refusal on his or her ability to rely 
on other management representations. 
EFFECTIVE DATE 
116. The effective date for this Statement is for engagements to examine or review MD&A 
presentations for periods ending on or after December 31 , 1997. Earlier application is encouraged. 
For nonpublic entities, the practitioner also obtains a written assertion that the presentation has 
been prepared using the published SEC rules and regulations (see paragraph 2). 
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34 
APPENDIX 
PROPOSED A M E N D M E N T TO 
STATEMENT ON AUDITING STANDARDS NO. 7 2 , 
LETTERS FOR UNDERWRITERS AND 
CERTAIN OTHER REQUESTING PARTIES 
(Amends Statement on Auditing Standards No. 72, 
AICPA, Professional Standards, vol. 1, AU sec. 634) 
[Explanation] 
This amendment is proposed to reflect the changes proposed in Statement on Standards for 
Attestation Engagements, Management's Discussion and Analysis. The amendment also includes 
conforming changes for standards issued subsequent to SAS No. 76. It also renumbers existing 
footnotes 25 through 3 1 . This amendment also includes new example R, an addition to the 
appendix of SAS No. 72. New language is shown in boldface italics; deletions are shown in strike-
through. The amendment is effective for letters that refer to an examination or a review of an 
MD&A presentation for a period ending December 3 1 , 1997, or thereafter. Earlier application is 
encouraged. 
[Text of Proposed Change] 
20. Accountants, when issuing a letter under the guidance provided in this statement, may not 
issue any additional letters or reports, under any other statement, to the underwriter or the other 
requesting parties identified in paragraphs 3, 4, and 5 (hereinafter referred to as the underwriter) 
in connection with the offering or placement of securities, in which the accountants comment on 
items for which commenting is otherwise precluded by this statement, such as square footage of 
facilities. 
22. This section (paragraphs 22 through 62) provides guidance on the format and possible 
contents of a typical comfort letter. It addresses how the comfort letter should be dated, to whom 
it may be addressed, and the contents of the introductory paragraph of the comfort letter. Further, 
it addresses the subjects that may be covered in a comfort letter: 
a. The independence of the accountants (paragraphs 31 and 32) 
b. Whether the unaudited financial statements and financial statement schedules included 
(incorporated by reference) in the registration statement comply as to form in all material 
respects with the applicable accounting requirements of the Act and the related published 
rules and regulations (paragraphs 33 and 34) 
c. Unaudited financial statements, condensed interim financial information, capsule financial 
information, pro forma financial information, financial forecasts, management's discussion 
and analysis, and changes in selected financial statement items during a period subsequent 
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to the date and period of the latest financial statements included (incorporated by 
reference) in the registration statement (paragraphs 35 through 53) 
d. Tables, statistics, and other financial information included (incorporated by reference) in 
the registration statement (paragraphs 54 through 62) 
e. Negative assurance as to whether certain non-financial information included (incorporated 
by reference) in the registration statement complies as to form in all material respects with 
Regulation S-K (paragraph 57) 
29. The accountants may refer in the introductory paragraphs of the comfort letter to the fact 
that they have issued reports on21 — 
a. Condensed financial statements that are derived from audited financial statements (see 
SAS No. 42, Reporting on Condensed Financial Statements and Selected Financial Data 
[AICPA, Professional Standards, vol. 1, AU sec. 552]). 
b. Selected financial data (see SAS No. 42). 
c. Interim financial information (see SAS No. 7 1 , Interim Financial Information [AICPA, 
Professional Standards, vol. 1, AU sec. 722]). 
d. Pro forma financial information (see SSAE No. 1, Attestation Standards [AICPA, 
Professional Standards, vol. 1, AT sec. 300, "Reporting on Pro Forma Financial 
Information"]). 
e. A financial forecast (see SSAE No. 1, Attestation Standards [AICPA, Professional 
Standards, vol. 1, AT sec. 200, "Financial Forecasts and Projections"]). 
f. Management's discussion and analysis (see SSAE No. X, Management's Discussion and 
Analysis [AICPA, Professional Standards, vol. 1, AT sec. XXX]). 
Such a reference should be to the accountants' reports that were previously issued, and if the 
reports were not included (incorporated by reference) in the registration statement, they may be 
attached to the comfort letter. In referring to previously issued reports, the accountants should 
not repeat their reports in the comfort letter or otherwise imply that they are reporting as of the 
date of the comfort letter or that they assume responsibility for the sufficiency of the procedures 
for the underwriter's purposes. However, for certain information on which they have reported, the 
accountants may agree to comment regarding compliance with published SEC requirements (see 
paragraphs 33 and 34). Accountants should not mention in a comfort letter reports issued in 
accordance with SAS No. 60, Communication of Internal Control Related Matters Noted in an Audit 
(AICPA, Professional Standards, vol. 1, AU sec. 325), or any restricted distribution reports issued 
to a client in connection with procedures performed on the client's internal controls in accordance 
wi th SSAE No. 2, as amended by SSAE No. 6, Reporting on an Entity's Internal Control Over 
Financial Reporting (AICPA, Professional Standards, vol. 1, AT sec. 400). 
21
 The accountants should not refer to or attach to the comfort letter any restricted distribution 
report, such as a report on agreed-upon procedures. 
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COMPLIANCE WITH SEC REQUIREMENTS 
33. The accountants may be requested to express an opinion on whether the financial s tatements 
covered by their report comply as to form w i th the pert inent published account ing requirements 
of the SEC.22 This may be done substantial ly as fo l lows: 
In our opinion [include phrase "except as disclosed in the registration statement" if 
applicable], the [identify the financial statements and financial statement schedules] audited 
by us and included (incorporated by reference) in the registration statement comply as to 
form in all material respects w i th the applicable accounting requirements of the Ac t and the 
related published rules and regulat ions.2 3 
If there is a material departure from the pert inent published requirements, the departure should be 
disclosed in the letter.24 An appropriate manner of doing this is shown in example K. 
3 4 . Accoun tan ts may provide posit ive assurance on compliance as to form w i th requirements 
under published SEC rules and regulations only w i th respect to those rules and regulations 
applicable to the form and content of f inancial s tatements and financial s tatement schedules that 
they have audited. Accountants are l imited to providing negative assurance on compliance as to 
form when the financial statements or financial s tatement schedules have not been audited. (For 
guidance in comment ing on compliance as to fo rm, see paragraph 37 regarding unaudited 
condensed interim financial in format ion, paragraph 42 regarding pro forma financial in format ion, 
paragraph 4 4 regarding a forecast, and paragraph 57 regarding Regulation S-K items.25) 
22The term published is used because accountants should not be expected to be familiar wi th, or 
express assurances on compliance wi th, informal positions of the SEC staff. 
23
 Certain financial statements may be incorporated in a registration statement under the Act by 
reference to filings under the Securities Exchange Act of 1934 (the 1934 Act). In those circumstances, 
the accountants may refer to whether the audited financial statements and financial statement schedules 
included (incorporated by reference) in the registration statement comply as to form in all material 
respects with the applicable accounting requirements of the 1934 Act and the related published rules and 
regulations (see example B [paragraph 64]). However, the accountants should not refer to compliance 
with the provisions of the 1934 Act regarding internal accounting control. See the auditing interpretation 
"Compliance With the Foreign Corrupt Practices Act of 1977" section 9642.10 .13) SSAE No. 2, as 
amended by SSAE No. 6, Reporting on an Entity's Internal Control Over Financial Reporting (AICPA, 
Professional Standards, vol. 1, AT sec. 400), paragraph 83. 
24
 Departures from published SEC requirements that require mention in a comfort letter ordinarily 
do not affect fair presentation in conformity wi th generally accepted accounting principles; however, if 
they do, the accountants will, of course, mention these departures in expressing their opinion and in 
consenting to the use of their report in the registration statement. If departures from published SEC 
requirements that require mention in a comfort letter either are not disclosed in the registration statement 
or have not been agreed to by representatives of the SEC, the accountants should carefully consider 
whether a consent to the use of their report in the registration statement should be issued. 
25
 Accountants should not comment in a comfort letter on compliance as to form of 
management's discussion and analysis (MD&A) with SEC rules and regulations; accountants may agree 
to examine or review MD&A in accordance with SSAE No. X, Management's Discussion and Analysis. 
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KNOWLEDGE OF THE INTERNAL CONTROL STRUCTURE 
36. The accountants should not comment in a comfort letter on (a) unaudited condensed interim 
financial information, (b) capsule financial information, (c) a financial forecast when historical 
financial statements provide a basis for one or more significant assumptions for the forecast, or 
id) changes in capital stock, increases in long-term debt and decreases in selected financial 
statement items, unless they have obtained knowledge of a client's internal control structure 
policies and procedures as they it relates to the preparation of both annual and interim financial 
information. Knowledge of the client's internal control structure over financial reporting includes 
knowledge of the control environment, the accounting system, and, to the extent appropriate 
control procedurees risk assessment, control activities, information and communication, and 
monitoring. Sufficient knowledge of a client's internal control structure policies and procedures 
as they it relates to the preparation of annual financial information ordinarily would have been 
acquired, and may have been acquired with respect to interim financial information, by the 
accountants who have audited a client's financial statements for one or more periods. When the 
accountants have not audited the most recent annual financial statements, and thus have not 
acquired sufficient knowledge of the entity's internal control structure policies and procedures, the 
accountants should perform procedures to obtain that knowledge. 
55. The accountants should refrain from commenting on certain matters in a comfort letter to 
which their competence as independent accountants has little relevance. Accordingly, eExcept 
as noted in the next sentence, they should comment only with respect to information (a) that is 
expressed in dollars (or percentages derived from such dollar amounts) and that has been obtained 
from accounting records that are subject to the internal control structure policies and procedures 
of the entity's accounting system client's controls over financial reporting (see paragraph 36) or 
(b) that has been derived directly from such accounting records by analysis or computation. The 
accountants may also comment on quantitative information that has been obtained from an 
accounting record if the information is of a typo that is subject to the same controls over financial 
reporting as the dollar amounts. Accountants should not comment on matters primarily involving 
the exercise of management's business judgment.—For example, changes between periods in 
gross profit ratios or not income may be caused by factors that are not necessarily within the 
expertise of accountants. The accountants should not comment on matters merely because they 
happen to be present and are capable of reading, counting, measuring, or performing other 
functions that might be applicable. Examples of matters that, unless subjected to the internal 
control structure policies and procedureos of the accounting system controls over financial reporting 
(which is not ordinarily the case), should not be commented on by the accountants31 include the 
square footage of facilities, number of employees (except as related to a given payroll period(s)), 
and backlog information. The accountants should not comment on tables, statistics, and other 
financial information relating to an unaudited period unless (a) they have performed an audit of the 
client's financial statements for a period including or immediately prior to the unaudited period or 
have completed an audit for a later period or (b) they have otherwise obtained knowledge of the 
client's internal control structure over financial reporting as provided for in paragraph 36 herein. 
31
 Accountants generally will be unable to comment on non-financial data presented in MD&A. 
However, when the accountants have conducted an examination or a review of MD&A in accordance 
with SSAE No. X, Management's Discussion and Analysis, they may agree to trace non-financial data 
presented outside MD&A to similar data included in the MD&A presentation. 
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In addition, the accountants should not comment on information subject to legal interpretation, 
such as beneficial share ownership. 
57. Certain financial information in registration statements is included because of specific 
requirements of Regulation S-K. Accountants may comment as to whether this information is in 
conformity with the disclosure requirements of Regulation S-K if the following conditions are met: 
a. The information is derived from the accounting records subject to the internal control 
structure policies and procedures of the entity's accounting system controls over financial 
reporting, or has been derived directly from such accounting records by analysis or 
computation. 
b. This information is capable of evaluation against reasonable criteria that have been 
established by the SEC. 
The following are the disclosure requirements of Regulation S-K32 that generally meet these 
conditions: 
• Item 3 0 1 , "Selected Financial Data" 
• Item 302, "Supplementary Financial Information" 
• Item 402, "Executive Compensation" 
• Item 503(d), "Ratio of Earnings to Fixed Charges" 
Accountants may not give positive assurance on conformity with the disclosure requirements of 
Regulation S-K; they are limited to giving negative assurance, since this information is not given 
in the form of financial statements and generally has not been audited by the accountants. Even 
wi th respect to the above-mentioned items, there may be situations in which it would be 
inappropriate to provide negative assurance with respect to conformity of this information with 
Regulation S-K because conditions (a) and (b) above have not been met. Since information 
relevant to Regulation S-K disclosure requirements other than those noted previously is generally 
not derived from the accounting records subject to the internal control structure policies and 
procedures of the entity's accounting system, controls over financial reporting, it is not appropriate 
for the accountants to comment on conformity of this information with Regulation S-K. The 
accountant's inability to comment on conformity with Regulation S-K does not preclude 
accountants from performing procedures and reporting findings with respect to this information. 
32
 Accountants should not comment in a comfort letter on compliance as to form of MD&A 
with SEC rules and regulations; accountants may agree to examine or review MD&A in accordance with 
SSAE No. X, Management's Discussion and Analysis. 
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[Text of Proposed Addition to Appendix] 
EXAMPLE R: COMFORT LETTER THAT INCLUDES REFERENCE TO EXAMINATION OF ANNUAL 
MD&A AND REVIEW OF INTERIM MD&A 
19. This example assumes the following circumstances.28 The prospectus (part I of the 
registration statement) includes audited consolidated balance sheets as of December 31, 19X5 and 
19X4, and audited consolidated statements of income, retained earnings (stockholders' equity), 
and cash flows for each of the three years in the period ended December 31, 19X5. Part I also 
includes an unaudited condensed consolidated balance sheet as of March 31, 19X6, and unaudited 
condensed consolidated statements of income, retained earnings (stockholders' equity), and cash 
flows for the three-month periods ended March 31, 19X6 and 19X5. Part II of the registration 
statement includes audited consolidated financial statement schedules for the three years ended 
December 31, 19X5. The accountants have examined the company's management's discussion 
and analysis (MD&A) for the year ended December 31, 19X5, in accordance with Statement on 
Standards for Attestation Engagements (SSAE) No. X; the accountants have also performed 
reviews of the company's unaudited condensed consolidated financial statements, referred to 
above, in accordance with SAS No. 71, and the company's MD&A for the three-month period 
ended March 31, 19X6, in accordance with SSAE No. X. The accountant's reports on the 
examination and review of MD&A have been previously issued, but not distributed publicly; none 
of these reports is included in the registration statement. The cutoff date is June 23, 19X6, and 
the letter is dated June 28, 19X6. The effective date is June 28,19X6. 
Each of the comments in the letter is in response to a requirement of the underwriting agreement. 
For purposes of example R, the income statement items of the current interim period are to be 
compared with those of the corresponding period of the preceding year. 
June 28, 19X6 
[Addressee] 
Dear Sirs: 
We have audited the consolidated balance sheets of The Blank Company, Inc. (the 
company) and subsidiaries as of December 31, 19X5 and 19X4, and the 
consolidated statements of income, retained earnings (stockholders' equity), and 
cash flows for each of the three years in the period ended December 31, 19X5, and 
the related financial statement schedules, all included in the registration statement 
(no. 33-00000) on Form S-1 filed by the company under the Securities Act of 1933 
(the Act); our reports with respect thereto are also included in that registration 
statement. The registration statement, as amended on June 28, 19X6, is herein 
referred to as the registration statement. Also, we have examined29 the company's 
28
 The example includes financial statements required by SEC regulations to be included in the 
filing. If additional financial information is covered by the comfort letter, appropriate modifications should 
be made. 
29
 If the accountant has performed a review of the company's annual MD&A, the opening 
paragraph of the comfort letter should be revised accordingly. 
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Management's Discussion and Analysis for the year ended December 31, 19X5, 
included in the registration statement, as indicated in our report dated March 28, 
19X6; our report with respect thereto is attached.30 We have also reviewed the 
unaudited condensed consolidated financial statements as of March 31, 19X6 and 
19X5, and for the three month periods then ended, included in the registration 
statement, as indicated in our report dated May 15, 19X6, and have also reviewed 
the company's Management's Discussion and Analysis for the three-month period 
ended March 31, 19X6, included in the registration statement; our reports with 
respect thereto are attached.31 
In connection with the registration statement— 
1. We are independent certified public accountants with respect to the company 
within the meaning of the Act and the applicable published rules and regulations 
thereunder. 
2. In our opinion [include the phrase "except as disclosed in the registration 
statement," if applicable], the consolidated financial statements and financial 
statement schedules audited by us and included in the registration statement 
comply as to form in all material respects with the applicable accounting 
requirements of the Act and the related published rules and regulations. 
3. We have not audited any financial statements of the company as of any 
date or for any period subsequent to December 31, 19X5; although we have 
conducted an audit for the year ended December 31, 19X5, the purpose (and 
therefore the scope) of the audit was to enable us to express our opinion on the 
consolidated financial statements as of December 31, 19X5, and for the year then 
ended, but not on the financial statements for any interim period within that year. 
Therefore, we are unable to and do not express any opinion on the unaudited 
condensed consolidated balance sheet as of March 31, 19X6, and the unaudited 
condensed consolidated statements of income, retained earnings (stockholders' 
equity), and cash flows for the three-month periods ended March 1, 19X6 and 
19X5, included in the registration statement, or on the financial position, results 
of operations, or cash flows as of any date or for any period subsequent to 
December 31, 19X5. 
4. We have not examined any management's discussion and analysis of the 
company as of or for any period subsequent to December 31, 19X5; although we 
have made an examination of the company's Management's Discussion and 
Analysis for the year ended December 31, 19X5 included in the company's 
registration statement, the purpose (and therefore the scope) of the examination 
was to enable us to express our opinion on such Management's Discussion and 
Analysis, but not on the management's discussion and analysis for any interim 
period within that year. Therefore, we are unable to and do not express any 
30
 The accountant has elected to attach the previously issued reports to the comfort letter (see 
paragraph 29). 
31
 See footnote 30 of the Appendix. 
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opinion on the Management's Discussion and Analysis for the three-month period 
ended March 31, 19X6, included in the registration statement, or for any period 
subsequent to March 31, 19X6. 
5. For purposes of this letter we have read the 19X6 minutes of meetings of the 
stockholders, the board of directors, and [include other appropriate committees, if 
any] of the company and its subsidiaries as set forth in the minute books at June 
23, 19X6, officials of the company having advised us that the minutes of all such 
meetings32 through that date were set forth therein; we have carried out other 
procedures to June 23, 19X6, as follows (our work did not extend to the period 
from June 24, 19X6, to June 28, 19X6, inclusive): 
a. With respect to the three-month periods ended March 31, 19X6 and 19X5, 
we have inquired of certain officials of the company who have responsibility 
for financial and accounting matters whether the unaudited condensed 
consolidated balance sheet as of March 31, 19X6, and the unaudited 
condensed consolidated statements of income, retained earnings 
(stockholders' equity), and cash flows for the three-month periods ended 
March 31, 19X6 and 19X5, included in the registration statement, comply 
as to form in all material respects with the applicable accounting 
requirements of the Act and the related published rules and regulations. 
b. With respect to the period from April 1, 19X6, to May 31, 19X6, we 
have— 
(i) Read the unaudited consolidated financial statements33 of the company and 
subsidiaries for April and May of both 19X5 and 19X6 furnished us by the 
company, officials of the company having advised us that no such financial 
statements as of any date or for any period subsequent to May 31, 19X6, 
were available. 
(ii) Inquired of certain officials of the company who have responsibility for 
financial and accounting matters whether the unaudited consolidated 
financial statements referred to in b(i) are stated on a basis substantially 
consistent with that of the audited consolidated financial statements 
included in the registration statement. 
The foregoing procedures do not constitute an audit of financial statements 
conducted in accordance with generally accepted auditing standards. Also, they 
would not necessarily reveal matters of significance with respect to the comments 
in the following paragraph. Accordingly, we make no representations regarding the 
sufficiency of the foregoing procedures for your purposes. 
6. Nothing came to our attention as a result of the foregoing procedures, however, 
32
 See footnote 3 of the Appendix. 
33
 See footnote 4 of the Appendix. 
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that caused us34 to believe that— 
a. The unaudited condensed consolidated financial statements described in 5a 
do not comply as to form in all material respects with the applicable 
accounting requirements of the Act and the related published rules and 
regulations. 
b. (i) At May 31, 19X6, there was any change in the capital stock, increase 
in long-term debt, or decrease in consolidated net current assets or 
stockholders' equity of the consolidated companies as compared with 
amounts shown in the March 31, 19X6, unaudited condensed consolidated 
balance sheet included in the registration statement, or (ii) for the period 
from April 1, 19X6, to May 31, 19X6, there were any decreases, as 
compared to the corresponding period in the preceding year, in consolidated 
net sales or in the total or per-share amounts of income before extraordinary 
items or of net income, except in all instances for changes, increases, or 
decreases that the registration statement discloses have occurred or may 
occur. 
7. As mentioned in 5b, company officials have advised us that no consolidated 
financial statements as of any date or for any period subsequent to May 31, 19X6, 
are available; accordingly, the procedures carried out by us with respect to changes 
in financial statement items after May 31, 19X6, have, of necessity, been even 
more limited than those with respect to the periods referred to in 5. We have 
inquired of certain officials of the company who have responsibility for financial and 
accounting matters whether (a) at June 23, 19X6, there was any change in the 
capital stock, increase in long-term debt or any decreases in consolidated net 
current assets or stockholders' equity of the consolidated companies as compared 
with amounts shown on the March 31, 19X6, unaudited condensed consolidated 
balance sheet included in the registration statement or (b) for the period from April 
1, 19X6, to June 23, 19X6, there were any decreases, as compared with the 
corresponding period in the preceding year, in consolidated net sales or in the total 
or per-share amounts of income before extraordinary items or of net income. On 
the basis of these inquiries and our reading of the minutes as described in 5, 
nothing came to our attention that caused us to believe that there was any such 
change, increase, or decrease, except in all instances for changes, increases, or 
decreases that the registration statement discloses have occurred or may occur. 
8. This letter is solely for the information of the addressees and to assist the 
underwriters in conducting and documenting their investigation of the affairs of the 
company in connection with the offering of the securities covered by the 
registration statement, and it is not to be used, circulated, quoted, or otherwise 
referred to within or without the underwriting group for any purpose, including but 
not limited to the registration, purchase, or sale of securities, nor is it to be filed 
with or referred to in whole or in part in the registration statement or any other 
document, except that reference may be made to it in the underwriting agreement 
or in any list of closing documents pertaining to the offering of the securities 
covered by the registration statement. 
34
 See footnote 5 of the Appendix. 
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